Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Parham, I. Rivera, Wendy Murillo, L. Navér, Natalia Largaespada, J. Albert, A. Karlsson (2011)
Short communication: high prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004.AIDS research and human retroviruses, 27 10
S. Oti (2013)
HIV and noncommunicable diseases: a case for health system buildingCurrent Opinion in HIV and AIDS, 8
T. Gsponer, M. Petersen, M. Egger, S. Phiri, M. Maathuis, A. Boulle, Patrick Musondad, H. Tweya, Karin Peter, B. Chi, O. Keiser (2012)
The causal effect of switching to second-line ART in programmes without access to routine viral load monitoringAIDS, 26
L. Else, L. Else, M. Douglas, Laura Dickinson, D. Back, Saye Khoo, Graham Taylor, Graham Taylor (2011)
Improved Oral Bioavailability of Lopinavir in Melt-Extruded Tablet Formulation Reduces Impact of Third Trimester on Lopinavir Plasma ConcentrationsAntimicrobial Agents and Chemotherapy, 56
N. Ama, E. Seloilwe (2010)
Estimating the cost of care giving on caregivers for people living with HIV and AIDS in Botswana: a cross-sectional studyJournal of the International AIDS Society, 13
(2012)
Novel therapeutic strategies targeting HIV integrase - art
A. Suthar, R. Granich, J. Mermin, A. Rie (2012)
Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis.Bulletin of the World Health Organization, 90 2
C. Garrido, J. Villacian, N. Zahonero, T. Pattery, Federico García, F. Gutiérrez, E. Caballero, M. Houtte, V. Soriano, C. Mendoza (2012)
Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing RegimensAntimicrobial Agents and Chemotherapy, 56
R. Hazra, Rachel Cohen, R. Gonin, J. Monteiro, C. Hofer, M. Negra, N. Ruz (2012)
Lipid levels in the second year of life among HIV-infected and HIV-exposed uninfected Latin American childrenAIDS, 26
C. Lai, C. Hung, Mao‐Yuan Chen, Hsin-Yun Sun, Ching-Lan Lu, Yu-Tzu Tseng, Shu-Fang Chang, Yi-Ching Su, Wen‐Chun Liu, Chia-Yin Hsieh, Pei‐Ying Wu, Sui‐Yuan Chang, Shan-Chwen Chang (2012)
Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan.The Journal of antimicrobial chemotherapy, 67 5
Justen Manasa, D. Katzenstein, S. Cassol, M. Newell, T. Oliveira (2012)
Primary drug resistance in South Africa: data from 10 years of surveys.AIDS research and human retroviruses, 28 6
P. Leelahavarong, Y. Teerawattananon, Pitsaphun Werayingyong, C. Akaleephan, Nakorn Premsri, C. Namwat, W. Peerapatanapokin, V. Tangcharoensathien (2011)
Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in ThailandBMC Public Health, 11
T. Kredo, T. Kredo, K. Mauff, J. Walt, J. Walt, L. Wiesner, G. Maartens, G. Maartens, K. Cohen, K. Cohen, Peter Smith, Peter Smith, K. Barnes (2011)
Interaction between Artemether-Lumefantrine and Nevirapine-Based Antiretroviral Therapy in HIV-1-Infected PatientsAntimicrobial Agents and Chemotherapy, 55
J. Bartlett, H. Ribaudo, C. Wallis, E. Aga, D. Katzenstein, W. Stevens, M. Norton, K. Klingman, M. Hosseinipour, J. Crump, K. Supparatpinyo, S. Badal-Faesen, Beatrice Kallungal, N. Kumarasamy (2012)
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settingsAIDS, 26
R. Granich, J. Kahn, R. Bennett, C. Holmes, N. Garg, Celicia Serenata, M. Sabin, C. Makhlouf-Obermeyer, Christina Mack, Phoebe Williams, L. Jones, C. Smyth, Kerry Kutch, Lo Ying-Ru, M. Vitoria, Y. Souteyrand, S. Crowley, E. Korenromp, B. Williams (2012)
Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050PLoS ONE, 7
R. Baggaley, K. Powers, M. Boily (2011)
What do mathematical models tell us about the emergence and spread of drug-resistant HIV?Current opinion in HIV and AIDS, 6 2
G. Aragonès, C. Alonso-Villaverde, Pedro Pardo-Reche, A. Rull, R. Beltrán-Debón, E. Rodríguez-Gallego, L. Fernández-Sender, J. Camps, J. Joven (2011)
Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphismBMC Medical Genetics, 12
B. Felipe, P. Pérez-Romero, M. Abad-Fernández, F. Fernández-Cuenca, Francisco Martinez-Fernandez, M. Trastoy, R. Mata, L. López-Cortés, M. Leal, P. Viciana, A. Vallejo (2011)
Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010Virology Journal, 8
F. Pulido, A. Hill, Y. Delft, C. Moecklinghoff (2012)
Impact of hepatitis C co-infection on response to antiretroviral treatment.AIDS reviews, 14 2
M. Kuniholm, Xiaojiang Gao, X. Xue, A. Kovacs, K. Anastos, D. Marti, R. Greenblatt, Mardge Cohen, H. Minkoff, S. Gange, M. Fazzari, M. Young, H. Strickler, M. Carrington (2011)
Human Leukocyte Antigen Genotype and Risk of HIV Disease Progression before and after Initiation of Antiretroviral TherapyJournal of Virology, 85
A. Deshpande, S. Karki, P. Recordon-Pinson, H. Fleury (2011)
Drug resistance mutations in HIV type 1 isolates from naive patients eligible for first line antiretroviral therapy in JJ Hospital, Mumbai, India.AIDS research and human retroviruses, 27 12
C. Charpentier, L. Larrouy, S. Matheron, F. Damond, O. Delelis, J. Mouscadet, P. Campa, G. Chêne, F. Brun-vezinet, D. Descamps (2011)
Long-Lasting Persistence of Integrase Resistance Mutations in HIV-2-Infected Patients after Raltegravir WithdrawalAntiviral Therapy, 16
P. Frange, Nelly Briand, V. Avettand-Fenoel, F. Veber, D. Moshous, N. Mahlaoui, C. Rouzioux, S. Blanche, M. Chaix (2011)
Lopinavir/Ritonavir-based Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-infected Naive Children: Rare Protease Inhibitor Resistance Mutations But High Lamivudine/Emtricitabine Resistance at the Time of Virologic FailureThe Pediatric Infectious Disease Journal, 30
K. Neukam, J. Mira, J. Ruíz-Morales, A. Rivero, A. Collado, A. Torres-Cornejo, D. Merino, I. Santos-Gil, J. Macías, M. González‐Serrano, Á. Camacho, G. Parra-García, J. Pineda (2011)
Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.The Journal of antimicrobial chemotherapy, 66 11
D. Beachler, K. Weber, J. Margolick, H. Strickler, R. Cranston, R. Burk, D. Wiley, H. Minkoff, Susheel Reddy, E. Stammer, M. Gillison, G. D’Souza (2011)
Risk Factors for Oral HPV Infection among a High Prevalence Population of HIV-Positive and At-Risk HIV-Negative AdultsCancer Epidemiology, Biomarkers & Prevention, 21
P. Hunt, H. Cao, C. Muzoora, I. Ssewanyana, John Bennett, N. Emenyonu, Annet Kembabazi, T. Neilands, D. Bangsberg, S. Deeks, Jeffrey Martin (2011)
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapyAIDS, 25
A. Aghokeng, C. Kouanfack, C. Laurent, E. Ebong, Arrah Atem-Tambe, C. Butel, C. Montavon, E. Mpoudi-Ngolé, E. Delaporte, M. Peeters (2011)
Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patientsAIDS, 25
X. Argemi, S. Dara, Seng You, J. Mattei, C. Courpotin, B. Simon, Y. Hansmann, D. Christmann, N. Lefèbvre (2012)
Impact of malnutrition and social determinants on survival of HIV-infected adults starting antiretroviral therapy in resource-limited settingsAIDS, 26
Ting Nie, M. Detorio, R. Schinazi (2011)
Universal Profiling of HIV-1 Pol for Genotypic Study and Resistance Analysis Across SubtypesAntiviral Therapy, 16
K. Sigaloff, R. Hamers, C. Wallis, C. Kityo, M. Siwale, P. Ive, M. Botes, K. Mandaliya, M. Wellington, A. Osibogun, W. Stevens, M. Vugt, T. Wit (2011)
Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 58
A. Yilmaz, R. Price, M. Gisslén (2012)
Antiretroviral drug treatment of CNS HIV-1 infection.The Journal of antimicrobial chemotherapy, 67 2
S. Vrouenraets, Ferdinand Wit, E. Garcia, M. Huber, K. Brinkman, Graeme Moyle, Pere Domingo, P. Tarr, Daniel Podzamczer, Matti Ristola, Gatell Jm, J. Livrozet, H. Furrer, P. Reiss (2012)
Longer Prior Exposure to Zidovudine/Lamivudine-Containing Combination Antiretroviral Therapy, Age, and Male Gender Are Each Associated With Reduced Subcutaneous Adipose TissueHIV Clinical Trials, 13
M. Franzetti, A. Lai, F. Simonetti, G. Bozzi, A. Luca, V. Micheli, P. Meraviglia, Paola Corsi, P. Bagnarelli, P. Almi, A. Zoncada, C. Balotta (2012)
High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.The Journal of antimicrobial chemotherapy, 67 5
E. Overton, P. Patel, K. Mondy, T. Bush, L. Conley, F. Rhame, E. Kojic, J. Hammer, K. Henry, J. Brooks (2012)
Cystatin C and baseline renal function among HIV-infected persons in the SUN Study.AIDS research and human retroviruses, 28 2
C. Charpentier, J. Gody, P. Tisserand, M. Matta, H. Péré, J. Fournier, Olivia Mbitikon, L. Bélec (2011)
Surveillance of Antiretroviral Drug Resistance Mutations in Untreated Young Children Living in the Central African RepublicAntiviral Therapy, 16
J. Pineda, K. Neukam, J. Mallolas, L. López-Cortés, J. Carton, P. Domingo, S. Moreno, J. Iribarren, B. Clotet, M. Crespo, I. Santos, E. Ortega, H. Knobel, M. Jiménez-Expósito, J. Macías (2012)
Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis.The Journal of infection, 64 2
M. Fisher, V. Cooper (2012)
HIV and ageing: premature ageing or premature conclusions?Current Opinion in Infectious Diseases, 25
J. Mosoko, W. Akam, P. Weidle, J. Brooks, A. Aweh, T. Kinge, S. Pals, P. Raghunathan (2011)
Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, CameroonJournal of the International AIDS Society, 14
G. Besson, D. McMahon, F. Maldarelli, J. Mellors (2012)
Short-course raltegravir intensification does not increase 2 long terminal repeat episomal HIV-1 DNA in patients on effective antiretroviral therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 3
B. Carvalho, L. Cardoso, S. Damasceno, M. Stefani (2011)
Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil.AIDS research and human retroviruses, 27 10
Olivia Goethals, Marcia Ginderen, Ann Vos, M. Cummings, K. Borght, L. Wesenbeeck, Maxim Feyaerts, A. Verheyen, V. Smits, M. Loock, K. Hertogs, D. Schols, R. Clayton (2011)
Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor.Antiviral research, 91 2
S. Shah, H. Xing, A. Altaf, Bing-Qiang Chen, L. Liao, Yujiang Jia, S. Vermund, Y. Shao (2011)
Antiretroviral drug resistance mutations among treated and treatment-naive patients in Pakistan: diversity of the HIV type 1 pol gene in Pakistan.AIDS research and human retroviruses, 27 12
J. Capeau, V. Bouteloup, C. Katlama, J. Bastard, V. Guiyedi, D. Salmon-Céron, C. Protopopescu, C. Leport, F. Raffi, G. Chêne (2012)
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatmentAIDS, 26
J. Fokam, R. Salpini, M. Santoro, V. Cento, C. Perno, V. Colizzi, P. Ndumbe, Charles Ntungen, Suzie Tetang, A. Nanfack, Désiré Komego, G. Cappelli (2011)
Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in CameroonThe Pediatric Infectious Disease Journal, 30
Traci Green, Samuel McGowan, M. Yokell, E. Pouget, J. Rich (2012)
HIV infection and risk of overdose: a systematic review and meta-analysisAIDS, 26
A. Judd (2011)
Early antiretroviral therapy in HIV-1-infected infants, 1996–2008: treatment response and duration of first-line regimensAIDS, 25
(2011)
Oncedaily antiretroviral therapy among treatment-experienced Muslim patients fasting for themonth of Ramadan
(2011)
Hypoxia-inducible factor-1 alpha/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling -art
R. Hamers, E. Straatsma, C. Kityo, C. Wallis, W. Stevens, K. Sigaloff, M. Siwale, F. Conradie, M. Botes, K. Mandaliya, M. Wellington, A. Osibogun, M. Vugt, T. Wit (2012)
Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance network.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
A. Victoriano, T. Okamoto (2012)
Transcriptional control of HIV replication by multiple modulators and their implication for a novel antiviral therapy.AIDS research and human retroviruses, 28 2
B. Chi, A. Mwango, M. Giganti, I. Sikazwe, C. Moyo, Linnaea Schuttner, L. Mulenga, C. Bolton-Moore, Namwinga Chintu, Robert Sheneberger, E. Stringer, J. Stringer (2011)
Comparative Outcomes of Tenofovir-Based and Zidovudine-Based Antiretroviral Therapy Regimens in Lusaka, ZambiaJAIDS Journal of Acquired Immune Deficiency Syndromes, 58
Lindsay Daniels, R. Raasch, A. Corbett (2012)
Implementation of targeted interventions to decrease antiretroviral-related errors in hospitalized patients.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 69 5
J. Muwonga, Samuel Edidi, C. Butel, N. Vidal, M. Monleau, Augustin Okenge, J. Mandjo, H. Mukumbi, J. Muyembe, F. Mbayo, D. Nzongola, E. Delaporte, F. Boillot, M. Peeters (2011)
Resistance to Antiretroviral Drugs in Treated and Drug-Naive Patients in the Democratic Republic of CongoJAIDS Journal of Acquired Immune Deficiency Syndromes, 57
K. Sigaloff, Tina Ramatsebe, R. Viana, T. Wit, C. Wallis, W. Stevens (2012)
Accumulation of HIV drug resistance mutations in patients failing first-line antiretroviral treatment in South Africa.AIDS research and human retroviruses, 28 2
S. Lelyveld, L. Gras, A. Kesselring, Shuangjie Zhang, F. Wolf, A. Wensing, A. Hoepelman (2012)
Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohortAIDS, 26
(2012)
Low rates of nucleoside reverse transcriptase inhibitor (NRTI) resistance detected in a well monitored cohort in South Africa accessing antiretroviral therapy
T. Nishijima, K. Tsukada, S. Takeuchi, A. Chiba, M. Honda, K. Teruya, H. Gatanaga, Y. Kikuchi, S. Oka (2011)
Antiretroviral therapy for treatment-naïve chronic HIV-1 infection with an axonal variant of Guillain-Barré syndrome positive for anti-ganglioside antibody: a case report.Internal medicine, 50 20
J. Downey, Meriem Attaf, G. Moyle, B. Gazzard, F. Gotch, N. Imami (2011)
T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsivenessAIDS, 25
R. Lazarus, H. Struthers, A. Violari (2010)
Starting HIV-positive babies on antiretroviral treatment: perspectives of mothers in Soweto, South Africa.Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners, 24 3
Jonathan Li, R. Paredes, H. Ribaudo, E. Svarovskaia, M. Kozal, K. Hullsiek, Michael Miller, D. Bangsberg, D. Kuritzkes (2012)
Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failureAIDS, 26
U. Hanning, I. Husstedt, T. Niederstadt, S. Evers, W. Heindel, S. Kloska (2011)
Cerebral signal intensity abnormalities on T2-weighted MR images in HIV patients with highly active antiretroviral therapy: relationship with clinical parameters and interval changes.Academic radiology, 18 9
Taryn Green, M. Archary, M. Gordon, N. Padayachi, Y. Lie, E. Anton, J. Reeves, A. Grobler, R. Bobat, H. Coovadia, T. Ndung’u (2012)
Drug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa.AIDS research and human retroviruses, 28 4
Jonathan Li, R. Paredes, H. Ribaudo, E. Svarovskaia, K. Metzner, M. Kozal, K. Hullsiek, M. Balduin, M. Jakobsen, A. Geretti, R. Thiébaut, L. Ostergaard, B. Masquelier, Jeffrey Johnson, Michael Miller, D. Kuritzkes (2011)
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.JAMA, 305 13
A. Kashuba, K. Patterson, Julie Dumond, M. Cohen (2012)
Pre-exposure prophylaxis for HIV prevention: how to predict successThe Lancet, 379
T. Doyle, Colette Smith, P. Vitiello, V. Cambiano, M. Johnson, A. Owen, A. Phillips, A. Geretti (2012)
Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 5
Ashika. Singh, H. Sunpath, Taryn Green, N. Padayachi, Keshni Hiramen, Y. Lie, E. Anton, R. Murphy, J. Reeves, D. Kuritzkes, T. Ndung’u (2011)
Drug Resistance and Viral Tropism in HIV-1 Subtype C-Infected Patients in KwaZulu-Natal, South Africa: Implications for Future Treatment OptionsJAIDS Journal of Acquired Immune Deficiency Syndromes, 58
R. Walensky, R. Wood, M. Fofana, N. Martinson, E. Losina, M. April, I. Bassett, Bethany Morris, K. Freedberg, A. Paltiel (2011)
The Clinical Impact and Cost-Effectiveness of Routine, Voluntary HIV Screening in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 56
L. Damme, A. Corneli, K. Ahmed, K. Agot, Johann Lombaard, S. Kapiga, M. Malahleha, Fredrick Owino, R. Manongi, Jacob Onyango, Lucky Temu, Modie Monedi, Paul Mak'Oketch, M. Makanda, Ilse Reblin, Shumani Makatu, L. Saylor, Haddie Kiernan, Stella Kirkendale, C. Wong, R. Grant, A. Kashuba, K. Nanda, Justin Mandala, K. Fransen, J. Deese, T. Crucitti, T. Mastro, Douglas Taylor (2012)
Preexposure prophylaxis for HIV infection among African women.The New England journal of medicine, 367 5
J. Kowalska, J. Reekie, A. Mocroft, P. Reiss, B. Ledergerber, J. Gatell, A. Monforte, A. Phillips, J. Lundgren, O. Kirk (2012)
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapyAIDS, 26
J. Casotti, L. Passos, F. Oliveira, C. Cerutti (2011)
Prevalence of discordant immunologic and virologic responses in patients with AIDS under antiretroviral therapy in a specialized care center in Brazil.Revista do Instituto de Medicina Tropical de Sao Paulo, 53 6
Jaideep Toor, Aman Sharma, Rajender Kumar, Pawan Gupta, P. Garg, S. Arora (2011)
Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysis.Antiviral research, 92 2
S. Gianella, V. Wyl, M. Fischer, B. Niederoest, M. Battegay, E. Bernasconi, M. Cavassini, A. Rauch, B. Hirschel, P. Vernazza, R. Weber, B. Joos, H. Günthard (2011)
Effect of Early Antiretroviral Therapy during Primary HIV-1 Infection on Cell-Associated HIV-1 Dna and Plasma HIV-1 RnaAntiviral Therapy, 16
Ana Wheelock, A. Eisingerich, G. Gomez, Emily Gray, M. Dybul, P. Piot (2012)
Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative studyBMJ Open, 2
K. Childs, T. Welz, A. Samarawickrama, F. Post (2012)
Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patientsAIDS, 26
R. Hamers, R. Schuurman, K. Sigaloff, C. Wallis, C. Kityo, M. Siwale, K. Mandaliya, P. Ive, M. Botes, M. Wellington, A. Osibogun, F. Wit, M. Vugt, W. Stevens, T. Wit (2012)
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.The Lancet. Infectious diseases, 12 4
Caroline Sloan, K. Champenois, P. Choisy, E. Losina, R. Walensky, B. Schackman, F. Ajana, H. Melliez, A. Paltiel, K. Freedberg, Y. Yazdanpanah (2012)
Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adultsAIDS, 26
K. Crawford, D. Ripin, Andrew Levin, Jennifer Campbell, C. Flexner (2012)
Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: a consensus statement.The Lancet. Infectious diseases, 12 7
J. Stein (2012)
Nutritional therapy to prevent dyslipidemia in patients starting antiretroviral therapy for human immunodeficiency virus.Journal of the American College of Cardiology, 59 11
Lamia Miri, A. Ouladlahsen, A. Kettani, R. Bensghir, Kamal Elfilali, L. Wakrim (2012)
Characterization of protease resistance-associated mutations in HIV type 1 drug-naive patients following the increasing prevalence of the CRF02_AG strain in Morocco.AIDS research and human retroviruses, 28 6
R. Ellis, Jayraan Badiee, F. Vaida, S. Letendre, R. Heaton, D. Clifford, A. Collier, B. Gelman, J. McArthur, S. Morgello, J. McCutchan, I. Grant (2011)
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapyAIDS, 25
M. Marazzi, L. Palombi, K. Nielsen‐Saines, J. Haswell, I. Zimba, N. Magid, E. Buonomo, P. Scarcella, S. Ceffa, Giovanna Paturzo, P. Narciso, G. Liotta (2011)
Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomesAIDS, 25
R. Medeiros, D. Junqueira, M. Matte, N. Barcellos, J. Chies, S. Almeida (2011)
Co‐circulation HIV‐1 subtypes B, C, and CRF31_BC in a drug‐naïve population from Southernmost Brazil: Analysis of primary resistance mutationsJournal of Medical Virology, 83
Tilahun Nigatu (2012)
Integration of HIV and Noncommunicable Diseases in Health Care Delivery in Low- and Middle-Income CountriesPreventing Chronic Disease, 9
Karina Berg, A. Litwin, Xuan Li, Moonseong Heo, J. Arnsten (2011)
Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 53 9
K. Knapp, Susan Brogly, D. Muenz, H. Spiegel, D. Conway, G. Scott, J. Talbot, D. Shapiro, J. Read (2012)
Prevalence of Congenital Anomalies in Infants With In Utero Exposure to AntiretroviralsThe Pediatric Infectious Disease Journal, 31
M. Stürmer, C. Stephan, P. Gute, G. Knecht, M. Bickel, H. Brodt, H. Doerr, L. Gürtler, P. Lecocq, M. Houtte (2011)
Comparison of Drug Resistance Scores for Tipranavir in Protease Inhibitor-Naïve Patients Infected with HIV-1 B and Non-B SubtypesAntimicrobial Agents and Chemotherapy, 55
S. Boyer, S. Koulla‐Shiro, C. Abé, B. Spire, J. Moatti (2011)
Implementing operational research to scale-up access to antiretroviral therapy for HIV infection: lessons learned from the Cameroonian experienceCurrent Opinion in HIV and AIDS, 6
S. Sungkanuparph, S. Kiertiburanakul, C. Sukasem, W. Chantratita (2012)
Discrepancies between WHO 2009 and IAS-USA 2009 lists for determining the rate of transmitted HIV-1 drug resistance: a prospective study.Journal of acquired immune deficiency syndromes, 59 1
A. Ciaranello, Ji-eun Park, L. Ramirez-Avila, K. Freedberg, R. Walensky, V. Leroy (2011)
Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventionsBMC Medicine, 9
Jingrong Ye, Hongyan Lu, Wei-shi Wang, Lei Guo, R. Xin, Shuang-qing Yu, Ting-chen Wu, Yi Zeng, Xiong He (2012)
The prevalence of drug resistance mutations among treatment-naive HIV-infected individuals in Beijing, China.AIDS research and human retroviruses, 28 4
A. Romero, O. Sued, T. Puig, A. Esteve, T. Pumarola, J. Casabona, V. González, L. Matas, C. Tural, I. Rodrigo, N. Margall, P. Domingo, A. Casanova, E. Ferrer, E. Caballero, E. Ribera, J. Farré, M. Amengual, G. Navarro, J. Prat, À. Masabeu, J. Simó, Carlos Villaverde, P. Barrufet, M. Sauca, X. Ortín, A. Orti, Rosa Navarro, J. Euras, J. Vilaró, M. Villà, S. Montull, C. Vilanova, F. Pujol, O. Díaz, J. Miró, Aeri Group, J. Miró, Prevalencia De (2011)
Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.Enfermedades infecciosas y microbiologia clinica, 29 7
Christine Hogan, Christine Hogan, V. DeGruttola, Xin Sun, S. Fiscus, C. Rio, C. Hare, M. Markowitz, E. Connick, B. Macatangay, K. Tashima, Beatrice Kallungal, R. Camp, Tia Morton, E. Daar, S. Little (2012)
The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.The Journal of infectious diseases, 205 1
Bethany Morris, C. Scott, T. Wilkin, P. Sax, R. Gulick, K. Freedberg, B. Schackman (2012)
Cost-effectiveness of Adding an Agent That Improves Immune Responses to Initial Antiretroviral Therapy (ART) in HIV-Infected Patients: Guidance for Drug DevelopmentHIV Clinical Trials, 13
S. Castell (2012)
Completion of isoniazid preventive therapy and survival in HIV-infected TST-positive adults in Tanzania [Correspondence].The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 16 4
Fm Asiimwe, David Moore, David Moore, W. Were, R. Nakityo, J. Campbell, A. Barasa, Jonathan Mermin, Frank Kaharuza (2011)
Clinical outcomes of HIV‐infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor‐based antiretroviral therapy in UgandaHIV Medicine, 13
K. Venkatesh, T. Flanigan, K. Mayer (2011)
Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing worldAIDS, 25
R. Lazzaretti, Regina Kuhmmer, E. Sprinz, C. Polanczyk, J. Ribeiro (2012)
Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial.Journal of the American College of Cardiology, 59 11
T. Brown, M. Glesby (2012)
Management of the metabolic effects of HIV and HIV drugsNature Reviews Endocrinology, 8
C. Anjos, G. Schettino, Marcelo Park, Vladimir Souza, A. Neto (2012)
A Randomized Trial of Noninvasive Positive End Expiratory Pressure in Patients With Acquired Immune Deficiency Syndrome and Hypoxemic Respiratory FailureRespiratory Care, 57
(2011)
Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda -art
E. Larson, Heidi O'bra, Jw Brown, T. Mbengashe, J. Klausner (2012)
Supporting the massive scale-up of antiretroviral therapy: the evolution of PEPFAR-supported treatment facilities in South Africa, 2005-2009BMC Public Health, 12
S. Weiser, A. Tsai, Reshma Gupta, E. Frongillo, A. Kawuma, J. Senkungu, P. Hunt, N. Emenyonu, Jennifer Mattson, Jeffrey Martin, D. Bangsberg (2012)
Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor settingAIDS, 26
F. Gutiérrez, M. Masiá (2011)
The role of HIV and antiretroviral therapy in bone disease.AIDS reviews, 13 2
J. Soria, M. Bull, C. Mitchell, A. Rosa, S. Dross, K. Kraft, R. Coombs, E. Ticona, L. Frenkel (2012)
Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru.AIDS research and human retroviruses, 28 4
C. Laurent, C. Kouanfack, G. Laborde-Balen, A. Aghokeng, J. Mbougua, S. Boyer, M. Carrieri, J. Mben, M. Dontsop, S. Kazé, N. Molinari, A. Bourgeois, E. Mpoudi-Ngolé, B. Spire, S. Koulla‐Shiro, E. Delaporte (2011)
Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.The Lancet. Infectious diseases, 11 11
K. Sabapathy, N. Ford, Khin Chan, Moe Kyaw, R. Elema, F. Smithuis, S. Floyd (2012)
Treatment Outcomes From the Largest Antiretroviral Treatment Program in Myanmar (Burma): A Cohort Analysis of Retention After Scale-UpJAIDS Journal of Acquired Immune Deficiency Syndromes, 60
A. Kambugu (2012)
Pre-ART HIV resistance testing in Africa: are we there yet?The Lancet. Infectious diseases, 12 4
G. Fabbriciani, G. Socio, M. Massarotti (2011)
Antiretroviral therapy and adverse skeletal effects.Mayo Clinic proceedings, 86 9
A. Luca, S. Giambenedetto, R. Maserati, N. Gianotti, P. Narciso, A. Antinori, G. Perri, M. Prosperi, F. Baldanti, V. Micheli, M. Zazzi, C. Perno, M. Santoro (2011)
Interpretation of Genotypic HIV-1 Resistance to Darunavir and Virological Response: Validation of Available Systems and of a New ScoreAntiviral Therapy, 16
C. Dola, Rubina Khan, Nathaniel Denicola, Mahin Amirgholami, Tara Benjamin, A. Bhuiyan, S. Longo (2011)
Combination antiretroviral therapy with protease inhibitors in HIV-infected pregnancy, 40
R. Yoder, W. Nyandiko, R. Vreeman, S. Ayaya, Peter Gisore, P. Braitstein, S. Wiehe (2012)
Long-Term Impact of the Kenya Postelection Crisis on Clinic Attendance and Medication Adherence for HIV-Infected Children in Western KenyaJAIDS Journal of Acquired Immune Deficiency Syndromes, 59
R. Hamers, K. Sigaloff, A. Wensing, C. Wallis, C. Kityo, M. Siwale, K. Mandaliya, P. Ive, M. Botes, M. Wellington, A. Osibogun, W. Stevens, T. Wit, R. Schuurman (2012)
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 11
E. Hoen, J. Berger, A. Calmy, S. Moon (2011)
Driving a decade of change: HIV/AIDS, patents and access to medicines for allJournal of the International AIDS Society, 14
C. Kennedy, V. Fonner, M. Sweat, F. Okero, R. Baggaley, K. O'reilly (2013)
Provider-Initiated HIV Testing and Counseling in Low- and Middle-Income Countries: A Systematic ReviewAIDS and Behavior, 17
A. Curran, E. Martinez, M. Saumoy, L. Río, M. Crespo, M. Larrousse, D. Podzamczer, J. Burgos, M. Loncá, P. Domingo, J. Gatell, E. Ribera (2012)
Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudyAIDS, 26
L. Menéndez-Arias, G. Betancor, Tania Matamoros (2011)
HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors.Antiviral research, 92 2
L. Mundy, A. Youk, G. McComsey, S. Bowlin (2012)
Overall benefit of antiretroviral treatment on the risk of fracture in HIV: nested case–control analysis in a health-insured populationAIDS, 26
Yan Zhao, K. Poundstone, J. Montaner, Zunyou Wu (2012)
New policies and strategies to tackle HIV/AIDS in China.Chinese medical journal, 125 7
G. Mutua, E. Sanders, P. Mugo, O. Anzala, J. Haberer, D. Bangsberg, B. Barin, J. Rooney, David Mark, P. Chetty, P. Fast, F. Priddy (2012)
Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex WorkersPLoS ONE, 7
T. Hallett, J. Baeten, R. Heffron, R. Barnabas, G. Bruyn, Í. Cremin, S. Delany, G. Garnett, G. Gray, L. Johnson, J. McIntyre, H. Rees, C. Celum (2011)
Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling StudyPLoS Medicine, 8
S. Rosen, M. Fox (2011)
Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic ReviewPLoS Medicine, 8
M. Chang, B. Torbett (2011)
Accessory mutations maintain stability in drug-resistant HIV-1 protease.Journal of molecular biology, 410 4
C. Wyen, B. Jensen, M. Hentrich, J. Siehl, M. Sabranski, S. Esser, D. Gillor, Markus Müller, J. Lunzen, T. Wolf, J. Bogner, J. Wasmuth, H. Christ, G. Fätkenheuer, C. Hoffmann (2012)
Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patientsAIDS, 26
G. Zyl, L. Merwe, M. Claassen, M. Zeier, W. Preiser (2011)
Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI‐based regimens in the western cape, South AfricaJournal of Medical Virology, 83
P. Maggi, D. Bartolozzi, P. Bonfanti, L. Calza, C. Cherubini, A. Biagio, S. Marcotullio, F. Montella, V. Montinaro, C. Mussini, P. Narciso, S. Rusconi, F. Vescini (2012)
Renal complications in HIV disease: between present and future.AIDS reviews, 14 1
J. Koeppe, Karen Lyda, Steven Johnson, C. Armon (2012)
Variables Associated With Decreasing Pain Among Persons Living With Human Immunodeficiency Virus: A Longitudinal Follow-up StudyThe Clinical Journal of Pain, 28
L. Waters, E. Smit (2012)
HIV-1 superinfectionCurrent Opinion in Infectious Diseases, 25
Leonard Msango, J. Downs, S. Kalluvya, B. Kidenya, Rodrick Kabangila, W. Johnson, D. Fitzgerald, R. Peck (2011)
Renal dysfunction among HIV-infected patients starting antiretroviral therapyAIDS, 25
M. Rabkin, S. Nishtar (2011)
Scaling Up Chronic Care Systems: Leveraging HIV Programs to Support Noncommunicable Disease ServicesJAIDS Journal of Acquired Immune Deficiency Syndromes, 57
Latoya Griffin, P. Annaert, K. Brouwer (2011)
Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.Journal of pharmaceutical sciences, 100 9
C. Aragonés-López, J. Pérez-Ávila, M. Fawzi, Arachu Castro (2012)
Quality of life of people with HIV/AIDS receiving antiretroviral therapy in Cuba: a cross-sectional study of the national population.American journal of public health, 102 5
M. Prosperi, A. Luca (2012)
Computational models for prediction of response to antiretroviral therapies.AIDS reviews, 14 2
B. Montague, B. Vuylsteke, A. Buvé (2011)
Sustainability of programs to reach high risk and marginalized populations living with HIV in resource limited settings: implications for HIV treatment and preventionBMC Public Health, 11
B. Chang, E. Sommers (2011)
Acupuncture and the Relaxation Response for Treating Gastrointestinal Symptoms in Hiv Patients on Highly Active Antiretroviral TherapyAcupuncture in Medicine, 29
M. Parczewski, M. Leszczyszyn‐Pynka, A. Urbańska, D. Bander, A. Boroń‐Kaczmarska (2011)
Genotypic tropism of antiretroviral‐treated patients with drug resistant HIV‐1Journal of Medical Virology, 83
Ye Ma, Fujie Zhang, Huiqin Li, Hao Wu, Jianbo Zhang, Yusheng Ding, De-cai Zhao, H. Fang, Shuntai Zhou, Zhong-fu Liu, Lan Zhang, C. Osborne, N. Séguy, Yan Zhao (2012)
Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
J. Baker, Jacqueline Neuhaus, D. Duprez, D. Cooper, J. Hoy, L. Kuller, F. Lampe, A. Liappis, N. Friis‐Møller, J. Otvos, N. Paton, R. Tracy, J. Neaton (2011)
Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapyAIDS, 25
A. Imaz, V. Falcó, E. Ribera (2011)
Antiretroviral salvage therapy for multiclass drug-resistant HIV-1-infected patients: from clinical trials to daily clinical practice.AIDS reviews, 13 3
H. Elinav, Keren Pops, D. Shasha, M. Korem, Michele Hauzi-Bashan, Z. Grossman, S. Maayan (2012)
HIV/AIDS profile and realities at a regional antiretroviral therapy clinic in Jerusalem: 12 years analysisScandinavian Journal of Infectious Diseases, 44
P. Ingiliz, M. Valantin, P. Preziosi, L. Finzi, R. Pais, L. Fedchuk, S. Dominguez, C. Katlama, T. Poynard, Y. Benhamou (2012)
Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis.Journal of hepatology, 56 1
C. Hung, Sui‐Yuan Chang, Kuan-Yeh Lee, Hsin-Yun Sun, Ching-Lan Lu (2011)
Risk and incidence of pulmonary diseases among HIV-infected patients in the era of combination antiretroviral therapy.American journal of respiratory and critical care medicine, 184 9
Federico García, M. Álvarez, Z. Fox, A. Garcia-Diaz, V. Guillot, M. Johnson, N. Chueca, A. Phillips, J. Hernández-Quero, A. Geretti (2011)
Predicting Antiretroviral Drug Resistance from the Latest or the Cumulative GenotypeAntiviral Therapy, 16
A. Marzocchetti, J. Schwarz, S. Giambenedetto, M. Colafigli, L. Bracciale, M. Fabbiani, M. Fantoni, E. Trecarichi, R. Cauda, A. Luca (2011)
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy.AIDS research and human retroviruses, 27 12
M. Tremeschin, D. Sartorelli, M. Cervi, B. Negrini, R. Salomão, J. Monteiro (2011)
Nutritional assessment and lipid profile in HIV-infected children and adolescents treated with highly active antiretroviral therapy.Revista da Sociedade Brasileira de Medicina Tropical, 44 3
C. Kouanfack, A. Aghokeng, A. Mondain, A. Bourgeois, Alain Kenfack, E. Mpoudi-Ngolé, J. Ducos, E. Delaporte, C. Laurent (2012)
Lamivudine-Resistant HBV Infection in HIV-Positive Patients Receiving Antiretroviral Therapy in a Public Routine Clinic in CameroonAntiviral Therapy, 17
K. Sigaloff, J. Calis, S. Geelen, M. Vugt, T. Wit (2011)
HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.The Lancet. Infectious diseases, 11 10
L. Palombi, R. Luhanga, C. Galluzzo, M. Andreotti, G. Liotta, S. Ceffa, J. Haswell, M. Marazzi, S. Vella, M. Giuliano (2011)
Limited Risk of Drug Resistance After Discontinuation of Antiretroviral Prophylaxis for the Prevention of Breastfeeding Transmission of HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 57
A. Vandamme, R. Camacho, F. Ceccherini‐Silberstein, A. Luca, L. Palmisano, D. Paraskevis, R. Paredes, M. Poljak, J. Schmit, V. Soriano, H. Walter, A. Sönnerborg (2011)
European recommendations for the clinical use of HIV drug resistance testing: 2011 update.AIDS reviews, 13 2
Untangling the web of antiretroviral price reductions
R. Gandhi, S. Deeks (2012)
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 5
R. Bedimo, N. Maalouf, Song Zhang, H. Drechsler, P. Tebas (2012)
Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agentsAIDS, 26
S. Lawn (2011)
Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 15 9
D. Frentz, C. Boucher, D. Vijver (2012)
Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world.AIDS reviews, 14 1
Todd Wills, Vivian Vega (2012)
Elvitegravir: a once-daily inhibitor of HIV-1 integraseExpert Opinion on Investigational Drugs, 21
M. Westin, F. Biscione, M. Fonseca, M. Ordones, Mirian Rodrigues, D. Greco, U. Tupinambás (2011)
Resistance-associated mutation prevalence according to subtypes B and non-B of HIV type 1 in antiretroviral-experienced patients in Minas Gerais, Brazil.AIDS research and human retroviruses, 27 9
M. Mulder, G. Yebra, Leticia Martín, L. Prieto, M. Mellado, P. Rojo, M. Muñoz-Fernández, S. Ory, J. Ramos, Á. Holguín (2011)
Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.The Journal of antimicrobial chemotherapy, 66 10
C. Gascun, A. Waters, C. Regan, Jane O’Halloran, G. Farrell, S. Coughlan, C. Bergin, W. Powderly, W. Hall (2012)
Documented prevalence of HIV type 1 antiretroviral transmitted drug resistance in Ireland from 2004 to 2008.AIDS research and human retroviruses, 28 3
A. Hearps, A. Maisa, Wan‐Jung Cheng, T. Angelovich, Gregor Lichtfuss, Clovis Palmer, A. Landay, A. Jaworowski, S. Crowe (2012)
HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapyAIDS, 26
(2010)
Experi - encing antiretroviral adherence : helping healthcare staff better understand adherence to paediatric antiretrovirals - art . no . 48
Diana Nurutdinova, T. Chrusciel, A. Zeringue, Jeffrey Scherrer, Z. Al‐Aly, J. Mcdonald, E. Overton (2012)
Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veteransAIDS, 26
M. Tamarit, C. Quereda, M. González-Rozas, Í. Corral, J. Casado (2012)
HIV type 1 viral encephalitis after development of viral resistance to plasma suppressive antiretroviral therapy.AIDS research and human retroviruses, 28 1
Verónica Briz, C. Palladino, M. Navarro, S. Ory, M. González-Tomé, Juan León, E. Núñez-Cuadros, M. José, J. Ramos, M. Muñoz-Fernández (2011)
Etravirine‐based highly active antiretroviral therapy in HIV‐1‐infected paediatric patientsHIV Medicine, 12
J. Campbell, David Moore, Richard Degerman, F. Kaharuza, W. Were, Emmy Muramuzi, G. Odongo, M. Wetaka, J. Mermin, J. Tappero (2012)
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 8
COHORT PROFILE Cohort Profile: The PharmAccess African
M. Ando, N. Yanagisawa, A. Ajisawa, K. Tsuchiya, K. Nitta (2011)
Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 26 10
M. Grijsen, R. Steingrover, F. Wit, S. Jurriaans, A. Verbon, K. Brinkman, M. Ende, R. Soetekouw, F. Wolf, J. Lange, H. Schuitemaker, J. Prins (2012)
No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM TrialPLoS Medicine, 9
J. McMahon, C. Wanke, J. Elliott, S. Skinner, A. Tang (2011)
Repeated Assessments of Food Security Predict CD4 Change in the Setting of Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 58
T. Nishijima, K. Tsukada, N. Nagata, Koji Watanabe, K. Teruya, H. Gatanaga, Y. Kikuchi, S. Oka (2011)
Antiretroviral therapy alone resulted in successful resolution of large idiopathic esophageal ulcers in a patient with acute retroviral syndrome.AIDS, 25 13
(2011)
Factors associated with shortcourse antiretroviral prophylaxis (dual therapy) adherence for PMTCT in Nkangala district, South Africa
K. Kranzer, N. Schaik, Unice Karmue, K. Middelkoop, E. Sebastian, S. Lawn, R. Wood, L. Bekker (2011)
High Prevalence of Self-Reported Undiagnosed HIV despite High Coverage of HIV Testing: A Cross-Sectional Population Based Sero-Survey in South AfricaPLoS ONE, 6
B. Westley, A. Delong, C. Tray, Dim Sophearin, E. Dufort, E. Nerrienet, Leeann Schreier, J. Harwell, R. Kantor (2012)
Prediction of treatment failure using 2010 World Health Organization Guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55 3
Aline Segatto, I. Júnior, V. Santos, K. Alves, D. Barbosa, Alexandre Filho, H. Monteiro (2011)
Lipodystrophy in HIV/AIDS patients with different levels of physical activity while on antiretroviral therapy.Revista da Sociedade Brasileira de Medicina Tropical, 44 4
A. Leibowitz, Alison Mendes, Katherine Desmond (2011)
Public Funding of HIV/AIDS Prevention, Treatment, and Support in CaliforniaJAIDS Journal of Acquired Immune Deficiency Syndromes, 58
Dayani Galato, A. Piovezan (2011)
Challenges to antiretroviral therapy: can one sentence in medication labelling reduce adherence?Expert Opinion on Pharmacotherapy, 12
G. Guaraldi, S. Zona, G. Orlando, F. Carli, C. Stentarelli, K. Luzi, E. Garlassi, M. Menozzi, P. Bagni, F. Adorni (2011)
Morphological and Metabolic Components of Lipodystrophy in Various Nevirapine-Based Highly Active Antiretroviral Therapy (HAART) RegimensClinical Drug Investigation, 31
Y. Lévy, R. Thiébaut, M. Gougeon, J. Molina, L. Weiss, P. Girard, A. Venet, P. Morlat, B. Poirier, A. Lascaux, C. Boucherie, D. Séréni, C. Rouzioux, J. Viard, C. Lane, J. Delfraissy, I. Sereti, G. Chêne (2012)
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIVAIDS, 26
S. Giambenedetto, M. Prosperi, I. Fanti, B. Bruzzone, S. Paolucci, G. Penco, G. Meini, A. Biagio, Elisabetta Paolini, V. Micheli, P. Meraviglia, P. Castelli, P. Corsi, A. Gonnelli, M. Fabbiani, M. Zazzi, A. Luca (2011)
Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 17 9
A. Cournil, Sabine Mercier-Deheuvels, A. Dupuy, J. Cristol, M. Anaky, F. Rouet, P. Fassinou, P. Msellati (2012)
Evolution of lipid levels in HIV-infected children treated or not with HAART in Abidjan, Cote d'Ivoire.Journal of tropical pediatrics, 58 1
Aditya Chandrasekhar, Amita Gupta (2011)
Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART?The American journal of clinical nutrition, 94 6
T. Heijman, R. Geskus, U. Davidovich, R. Coutinho, M. Prins, I. Stolte (2012)
Less decrease in risk behaviour from pre-HIV to post-HIV seroconversion among MSM in the combination antiretroviral therapy era compared with the pre-combination antiretroviral therapy eraAIDS, 26
T. Goetghebuer, J. chenadec, E. Haelterman, L. Galli, C. Dollfus, C. Thorne, A. Judd, O. Keiser, J. Ramos, J. Lévy, J. Warszawski (2012)
Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 6
M. Barro, Jérôme Somé, V. Foulongne, Yaya Diasso, Emmanuelle Zouré, H. Hien, Rouet François, S. Michel, A. Drabo, Hassane Tamboura, Adama Ouiminga, S. Diagbouga, A. Hien, S. Yaméogo, P. Perre, B. Nacro, P. Msellati (2011)
Short-Term Virological Efficacy, Immune Reconstitution, Tolerance, and Adherence of Once-Daily Dosing of Didanosine, Lamivudine, and Efavirenz in HIV-1–Infected African Children: ANRS 12103 BurkinameJAIDS Journal of Acquired Immune Deficiency Syndromes, 57
M. Jordan, D. Bennett, M. Wainberg, D. Havlir, S. Hammer, C. Yang, L. Morris, M. Peeters, A. Wensing, N. Parkin, J. Nachega, A. Phillips, A. Luca, E. Geng, A. Calmy, E. Raizes, P. Sandstrom, C. Archibald, J. Perriëns, C. McClure, S. Hong, J. McMahon, N. Dedes, D. Sutherland, S. Bertagnolio (2012)
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
H. Sheehan, J. Benetucci, E. Muzzio, L. Redini, J. Naveira, Marcela Segura, M. Weissenbacher, A. Tang (2011)
High rates of serum selenium deficiency among HIV- and HCV-infected and uninfected drug users in Buenos Aires, ArgentinaPublic Health Nutrition, 15
N. Duc, B. Hien, N. Wagar, Tran Tram, L. Giang, Chunfu Yang, M. Wolfe, N. Hien, N. Tuan (2012)
Surveillance of transmitted HIV drug resistance using matched plasma and dried blood spot specimens from voluntary counseling and testing sites in Ho Chi Minh City, Vietnam, 2007-2008.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
A. Waheed, E. Freed (2012)
HIV type 1 Gag as a target for antiviral therapy.AIDS research and human retroviruses, 28 1
Kasane Naito, H. Ueno, M. Sekine, Munekazu Kanemitsu, T. Ohshita, Takeshi Nakamura, T. Yamawaki, M. Matsumoto (2012)
Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI Study.Internal medicine, 51 2
V. Cartsos, P. Palaska, A. Zavras (2012)
Antiretroviral Prophylaxis and the Risk of Cleft Lip and Palate: Preliminary Signal Detection in the Food and Drug Administration's Adverse Events Reporting System DatabaseThe Cleft Palate-Craniofacial Journal, 49
(2011)
The development of an expert system to predict virological response to HIV therapy as part of an online treatment
N. Dvali, M. Parker, N. Chkhartishvili, L. Sharvadze, N. Gochitashvili, A. Abutidze, M. Karchava, J. Dehovitz, T. Tsertsvadze (2012)
Characterization of HIV‐1 subtypes and drug resistance mutations among individuals infected with HIV in GeorgiaJournal of Medical Virology, 84
Nomvuyo Mothobi, B. Brew (2012)
Neurocognitive dysfunction in the highly active antiretroviral therapy eraCurrent Opinion in Infectious Diseases, 25
V. Oliveira, Inês Bártolo, P. Borrego, C. Rocha, E. Valadas, J. Barreto, Elsa Almeida, F. Antunes, N. Taveira (2011)
Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde Islands.AIDS research and human retroviruses, 28 5
A. Muchedzi, W. Chandisarewa, J. Keatinge, L. Stranix-Chibanda, G. Woelk, E. Mbizvo, A. Shetty (2010)
Factors associated with access to HIV care and treatment in a prevention of mother to child transmission programme in urban ZimbabweJournal of the International AIDS Society, 13
M. Skovdal, C. Campbell, C. Madanhire, Z. Mupambireyi, C. Nyamukapa, S. Gregson (2011)
Masculinity as a barrier to men's use of HIV services in ZimbabweGlobalization and Health, 7
M. Bolland, A. Grey, A. Horne, S. Briggs, Mark Thomas, R. Ellis-Pegler, Greg Gamble, I. Reid (2012)
Stable bone mineral density over 6 years in HIV‐infected men treated with highly active antiretroviral therapy (HAART)Clinical Endocrinology, 76
R. Weigel, Janne Estill, M. Egger, A. Harries, S. Makombe, H. Tweya, A. Jahn, O. Keiser (2012)
Mortality and loss to follow-up in the first year of ART: Malawi national ART programmeAIDS, 26
Kate Groh, C. Audet, A. Baptista, M. Sidat, Alfredo Vergara, S. Vermund, T. Moon (2011)
Barriers to antiretroviral therapy adherence in rural MozambiqueBMC Public Health, 11
S. Huntington, L. Bansi, C. Thorne, Jane Anderson, M. Newell, G. Taylor, D. Pillay, T. Hill, P. Tookey, C. Sabin (2011)
Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conceptionAIDS, 25
A. López-Martínez, Nathan Brien, Y. Caro-Vega, B. Crabtree-Ramírez, J. Sierra-Madero (2012)
Different Baseline Characteristics and Different Outcomes of HIV-Infected Patients Receiving HAART Through Clinical Trials Compared With Routine Care in MexicoJAIDS Journal of Acquired Immune Deficiency Syndromes, 59
B. Eley, T. Meyers (2011)
Antiretroviral Therapy for Children in Resource-Limited SettingsPediatric Drugs, 13
T. Bunupuradah, P. Chetchotisakd, J. Ananworanich, Warangkana Munsakul, S. Jirajariyavej, P. Kantipong, W. Prasithsirikul, S. Sungkanuparph, C. Bowonwatanuwong, V. Klinbuayaem, S. Kerr, J. Sophonphan, Sorakij Bhakeecheep, B. Hirschel, K. Ruxrungtham (2012)
A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star StudyAntiviral Therapy, 17
(2011)
Adherence to antiretroviral therapy and its correlates among HIV-infected children at an HIV clinic in NewDelhi
K. Rompay (2012)
The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies.AIDS research and human retroviruses, 28 1
Lucy Reynolds (2011)
HIV as a chronic disease considerations for service planning in resource-poor settingsGlobalization and Health, 7
Ravindra Gupta, M. Jordan, B. Sultan, A. Hill, Daniel Davis, J. Gregson, A. Sawyer, R. Hamers, N. Ndembi, D. Pillay, S. Bertagnolio (2012)
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysisLancet, 380
M. Mugavero, K. Amico, A. Westfall, H. Crane, A. Zinski, J. Willig, Julia Dombrowski, W. Norton, J. Raper, M. Kitahata, M. Saag (2012)
Early Retention in HIV Care and Viral Load Suppression: Implications for a Test and Treat Approach to HIV PreventionJAIDS Journal of Acquired Immune Deficiency Syndromes, 59
Zhiliang Wang, Renbing Jia, S. Ge, Taiwen He, Yunzhi Zhang, Yalin Yang, Yefei Wang, W. Shi, Yongrong Ji, Fuxiang Ye, Ping Chen, Jian-feng Lu, Jing Sun, Xiaofan Xu, Yixiong Zhou, P. Gu, Min Luo, Hongzhou Lu, Xianqun Fan (2012)
Ocular complications of human immunodeficiency virus infection in eastern china.American journal of ophthalmology, 153 2
F. Boufassa, C. Goujard, J. Viard, R. Carlier, B. Lefebvre, P. Yeni, O. Bouchaud, J. Capeau, L. Meyer, C. Vigouroux (2012)
Immune Deficiency Could be An Early Risk Factor for Altered Insulin Sensitivity in Antiretroviral-Naive HIV-1-Infected Patients: The Anrs Copana CohortAntiviral Therapy, 17
S. Karim, C. Baxter (2012)
Overview of microbicides for the prevention of human immunodeficiency virus.Best practice & research. Clinical obstetrics & gynaecology, 26 4
M. Schull, R. Cornick, Sandy Thompson, G. Faris, L. Fairall, Barry Burciul, S. Sodhi, B. Draper, M. Joshua, Martha Mondiwa, H. Banda, Damson Kathyola, E. Bateman, M. Zwarenstein (2011)
From PALSA PLUS to PALM PLUS: adapting and developing a South African guideline and training intervention to better integrate HIV/AIDS care with primary care in rural health centers in MalawiImplementation Science : IS, 6
L. Aurpibul, T. Puthanakit, Sineenart Taejaroenkul, T. Sirisanthana, V. Sirisanthana (2012)
Recovery From Lipodystrophy in HIV–infected Children After Substitution of Stavudine With Zidovudine in a Non-nucleoside Reverse Transcriptase Inhibitor–based Antiretroviral TherapyThe Pediatric Infectious Disease Journal, 31
W. Muronya, Esther Sanga, George Talama, J. Kumwenda, J. Oosterhout (2011)
Cardiovascular risk factors in adult Malawians on long-term antiretroviral therapy.Transactions of the Royal Society of Tropical Medicine and Hygiene, 105 11
T. Khawcharoenporn, A. Apisarnthanarak, W. Manosuthi, S. Sungkanuparph, L. Mundy (2012)
Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 16 3
(1997)
Joint United Nations Programme on HIV/AIDS (UNAIDS)-WHO. Revised recommendations for the selection and use of HIV antibody tests.Releve epidemiologique hebdomadaire, 72 12
Mallory Johnson, S. Dilworth, Jonelle Taylor, T. Neilands (2010)
Improving Coping Skills for Self-management of Treatment Side Effects Can Reduce Antiretroviral Medication Nonadherence among People Living with HIVAnnals of Behavioral Medicine: A Publication of the Society of Behavioral Medicine, 41
A. Phillips, D. Pillay, G. Garnett, D. Bennett, M. Vitoria, V. Cambiano, J. Lundgren (2011)
Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settingsAIDS, 25
G. Hunt, J. Ledwaba, A. Basson, J. Moyes, Cheryl Cohen, Beverly Singh, S. Bertagnolio, Michael Jordan, Michael Jordan, A. Puren, Lynn Morris (2012)
Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
C. Innes, R. Hamilton, C. Hoffmann, P. Hippner, K. Fielding, A. Grant, G. Churchyard, S. Charalambous (2012)
A novel HIV treatment model using private practitioners in South AfricaSexually Transmitted Infections, 88
M. Oette, S. Reuter, R. Kaiser, Thomas Lengauer, G. Fätkenheuer, H. Knechten, M. Hower, H. Pfister, D. Häussinger (2012)
Epidemiology of Transmitted Drug Resistance in Chronically HIV-Infected Patients in Germany: The RESINA Study 2001–2009Intervirology, 55
(2012)
Palliative Care and Support for Persons with HIV/ AIDS in 7 AfricanCountries: Implementation Experience and Future Priorities
Gavin Henderson, Sook-Kyung Lee, D. Irlbeck, Janera Harris, Melissa Kline, Elizabeth Pollom, N. Parkin, R. Swanstrom (2011)
Interplay between Single Resistance-Associated Mutations in the HIV-1 Protease and Viral Infectivity, Protease Activity, and Inhibitor SensitivityAntimicrobial Agents and Chemotherapy, 56
R. Amico (2012)
Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectivenessCurrent Opinion in HIV and AIDS, 7
C. Charpentier, P. Bellecave, M. Cissé, S. Mamadou, Mandiou Diakité, G. Peytavin, S. Tchiombiano, P. Teisseire, Louis Pizarro, A. Storto, F. Brun-vezinet, C. Katlama, V. Calvez, A. Marcelin, B. Masquelier, D. Descamps (2011)
High Prevalence of Antiretroviral Drug Resistance among HIV-1-Untreated Patients in Guinea-Conakry and in NigerAntiviral Therapy, 16
J. Dzangare, E. Gonese, O. Mugurungi, T. Shamu, T. Apollo, D. Bennett, K. Kelley, M. Jordan, M. Jordan, C. Chakanyuka, F. Cham, Richard Banda (2012)
Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
S. Hermans, S. Hermans, S. Hermans, F. Leth, Yukari Manabe, Yukari Manabe, A. Hoepelman, J. Lange, A. Kambugu (2012)
Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort studyHIV Medicine, 13
S. Resch, E. Korenromp, J. Stover, M. Blakley, C. Krubiner, Kira Thorien, R. Hecht, R. Atun (2011)
Economic Returns to Investment in AIDS Treatment in Low and Middle Income CountriesPLoS ONE, 6
S. Nixon, J. Hanass-Hancock, A. Whiteside, T. Barnett (2011)
The increasing chronicity of HIV in sub-Saharan Africa: Re-thinking "HIV as a long-wave event" in the era of widespread access to ARTGlobalization and Health, 7
Hai Nguyen, P. Pitakpolrat, S. Sirivichayakul, C. Delaugerre, K. Ruxrungtham (2012)
Minority HIV‐1 resistant variants in recent infection and in patients who failed first‐line antiretroviral therapy with no detectable resistance‐associated mutations in ThailandJournal of Medical Virology, 84
D. Bui, F. Mesquita, T. Do, Masaya Kato, Thi Nguyen, Thi Nguyen, A. Poon (2012)
Treatment 2.0 Pilot in Vietnam-Early Progress and ChallengesWorld Journal of AIDS, 2
O. Lada, A. Gervais, M. Branger, G. Peytavin, B. Roquebert, G. Collin, Gil Fraqueiro, R. Moucari, G. Hamet, M. Martinot‐Peignoux, S. Matheron, P. Marcellin (2012)
Long‐term outcome of primary non‐responders to tenofovir therapy in HIV/HBV‐co‐infected patients: impact of HBV genotype GLiver International, 32
S. Alcaro, C. Alteri, A. Artese, F. Ceccherini‐Silberstein, Giosuè Costa, F. Ortuso, A. Bertoli, F. Forbici, M. Santoro, Lucia Parrotta, P. Flandre, B. Masquelier, D. Descamps, V. Calvez, A. Marcelin, C. Perno, Tobias Sing, V. Svicher (2011)
Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV‐1 Non‐nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and EtravirineChemMedChem, 6
Innovative financing mechanisms for HIV prevention and care: PEPFAR, CHAI, UNAIDS
K. Sigaloff, R. Hamers, C. Wallis, C. Kityo, M. Siwale, P. Ive, M. Botes, K. Mandaliya, M. Wellington, A. Osibogun, W. Stevens, M. Vugt, T. Wit (2012)
Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa.The Journal of infectious diseases, 205 11
M. Oette, E. Schülter, M. Rosen-Zvi, Y. Peres, M. Zazzi, A. Sönnerborg, D. Struck, A. Altmann, R. Kaiser (2012)
Efficacy of Antiretroviral Therapy Switch in HIV-Infected Patients: A 10-Year Analysis of the EuResist CohortIntervirology, 55
I. Jarrín, N. Pantazis, M. Gill, R. Geskus, S. Pérez-Hoyos, L. Meyer, M. Prins, G. Touloumi, Anne Johnson, O. Hamouda, Patricia Olalla, K. Porter, J. Amo, Cascade Collaboration, In Eurocoord (2012)
Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 1
M. Prosperi, S. Giambenedetto, I. Fanti, G. Meini, B. Bruzzone, A. Callegaro, G. Penco, P. Bagnarelli, V. Micheli, Elisabetta Paolini, A. Biagio, V. Ghisetti, M. Pietro, M. Zazzi, A. Luca, et al. (2011)
A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy RegimenBMC Medical Informatics and Decision Making, 11
W. Gormley, J. McCaffery, E. Quain (2011)
Moving Forward on Human Resources for Health: Next Steps for Scaling Up Toward Universal Access to HIV/AIDS Prevention, Treatment, and CareJAIDS Journal of Acquired Immune Deficiency Syndromes, 57
A. Suthar, S. Lawn, J. Amo, H. Getahun, C. Dye, D. Sculier, T. Sterling, R. Chaisson, B. Williams, A. Harries, R. Granich (2012)
Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-AnalysisPLoS Medicine, 9
J. Lunzen, F. Maggiolo, J. Arribas, A. Rakhmanova, P. Yeni, B. Young, J. Rockstroh, S. Almond, I. Song, C. Brothers, S. Min (2012)
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial.The Lancet. Infectious diseases, 12 2
J. Pfeiffer, P. Montoya, A. Baptista, M. Karagianis, Marilia Pugas, M. Micek, W. Johnson, K. Sherr, S. Gimbel, Shelagh Baird, B. Lambdin, S. Gloyd (2010)
Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique - a case studyJournal of the International AIDS Society, 13
(2011)
Global AIDS response continues to show results as a record number if people access treatment and rates of new HIV infections fall by nearly 25
M. Wainberg, G. Zaharatos, B. Brenner (2011)
Development of antiretroviral drug resistance.The New England journal of medicine, 365 7
M. Murray, Robert Hogg, V. Lima, Margaret May, David Moore, S. Abgrall, Mathias Bruyand, A. Monforte, C. Tural, M. Gill, Ross Harris, P. Reiss, Amy Justice, O. Kirk, M. Saag, M. Saag, C. Smith, Rainer Weber, J. Rockstroh, P. Khaykin, J. Sterne (2012)
The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysisHIV Medicine, 13
M. Akanbi, K. Scarsi, B. Taiwo, R. Murphy (2012)
Combination Nucleoside/Nucleotide Reverse Transcriptase Inhibitors for Treatment of HIV InfectionExpert Opinion on Pharmacotherapy, 13
Clinton Health Access Initiative (CHAI)
L. Katsidzira, A. Ramsay, R. Makunike-Mutasa, M. Borok (2011)
Complete regression of early diffuse B-cell lymphoma in an HIV-positive patient on antiretroviral therapy aloneInternational Journal of STD & AIDS, 22
A. Rodger, A. Phillips, J. Lundgren (2011)
Prevention of HIV-1 infection with antiretroviral therapy.The New England journal of medicine, 365 20
J. Forrester, Martin Rhee, Barbara McGovern, Richard Sterling, T. Knox, Norma Terrin (2012)
The association of HIV viral load with indirect markers of liver injuryJournal of Viral Hepatitis, 19
P. Namuwenge, J. Mukonzo, N. Kiwanuka, R. Wanyenze, R. Byaruhanga, K. Bissell, R. Zachariah (2012)
Loss to follow up from isoniazid preventive therapy among adults attending HIV voluntary counseling and testing sites in Uganda.Transactions of the Royal Society of Tropical Medicine and Hygiene, 106 2
E. Mills, Celestin Bakanda, J. Birungi, Keith Chan, N. Ford, C. Cooper, J. Nachega, M. Dybul, R. Hogg (2011)
Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From UgandaAnnals of Internal Medicine, 155
A. Zuger (1997)
Adherence to highly active antiretroviral therapy.AIDS clinical care, 9 11
Federico García, Santiago Pérez-Cachafeiro, V. Guillot, M. Álvarez, P. Pérez-Romero, M. Pérez-Elías, I. Viciana, J. Blanco, María López-Diéguez, C. Mendoza (2011)
Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS).Antiviral research, 91 2
R. Hamers, A. Sawyer, M. Tuohy, W. Stevens, T. Wit, A. Hill (2012)
Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysisAIDS, 26
L. Liao, H. Xing, Y. Dong, Guang-ming Qin, Yanling Ma, Hongyan Lu, Lin Chen, Lan Zhang, C. Osborne, N. Séguy, Daying Wei, Feng-Qi Sun, Juan Yang, Y. Ruan, Y. Shao (2012)
Surveys of transmitted HIV drug resistance in 7 geographic Regions in China, 2008-2009.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
J. Gatell (2011)
Antiretroviral therapy for HIV: do subtypes matter?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 53 11
C. Cardoso, J. Pinto, T. Candiani, I. Carvalho, Renato Linhares, E. Goulart (2012)
The impact of highly active antiretroviral therapy on the survival of vertically hIV-infected children and adolescents in Belo horizonte, Brazil
D. Pocaterra, L. Carenzi, E. Ricci, Davide Minisci, M. Schiavini, P. Meraviglia, M. Bevilacqua, P. Zucchi, P. Bonfanti, G. Rizzardini (2011)
Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy?AIDS, 25 11
M. Rabkin, W. El-Sadr (2011)
Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseasesGlobal Public Health, 6
R. Heffron, K. Ngure, N. Mugo, C. Celum, A. Kurth, K. Curran, J. Baeten (2012)
Willingness of Kenyan HIV-1 Serodiscordant Couples to Use Antiretroviral-Based HIV-1 Prevention StrategiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 61
A. Mtambo, K. Chan, A. Shen, V. Lima, R. Hogg, J. Montaner, D. Moore (2011)
Treatment limitations imposed by antiretroviral drug resistance mutations: implication for choices of first line regimens in resource‐limited settingsHIV Medicine, 13
R. Bhatia, Patrick Ryscavage, B. Taiwo (2012)
Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapyJournal of NeuroVirology, 18
M. Mugavero, M. May, H. Ribaudo, R. Gulick, S. Riddler, R. Haubrich, S. Napravnik, S. Abgrall, A. Phillips, Ross Harris, M. Gill, F. Wolf, R. Hogg, H. Günthard, G. Chêne, A. Monforte, J. Guest, Colette Smith, J. Murillas, J. Berenguer, C. Wyen, P. Domingo, M. Kitahata, J. Sterne, M. Saag (2011)
Comparative Effectiveness of Initial Antiretroviral Therapy Regimens: ACTG 5095 and 5142 Clinical Trials Relative to ART-CC Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 58
Samreen Mansor, V. Breiting, K. Dahlstrøm, Å. Andersen, O. Andersen, L. Christensen (2011)
Polyacrylamide Gel Treatment of Antiretroviral Therapy-induced Facial Lipoatrophy in HIV PatientsAesthetic Plastic Surgery, 35
O. Avdeeva, J. Lazarus, M. Aziz, R. Atun (2011)
The Global Fund's resource allocation decisions for HIV programmes: addressing those in needJournal of the International AIDS Society, 14
M. Estrella, G. Kirk, S. Mehta, T. Brown, D. Fine, M. Atta, G. Lucas (2012)
Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug usersAIDS, 26
C. Raynaud, N. Roche, C. Chouaid (2011)
Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspectsRespiratory Research, 12
V. Tran, A. Ishizaki, C. Nguyen, H. Hoang, H. Pham, Xiuqiong Bi, T. Pham, H. Ichimura (2012)
No increase of drug-resistant HIV type 1 prevalence among drug-naive individuals in Northern Vietnam.AIDS research and human retroviruses, 28 10
H. Annaz, P. Recordon-Pinson, N. Baba, O. Sedrati, S. Mrani, H. Fleury (2011)
Presence of drug resistance mutations among drug-naive patients in Morocco.AIDS research and human retroviruses, 27 8
J. Levison, C. Orrell, E. Losina, Zhigang Lu, K. Freedberg, R. Wood (2011)
Early Outcomes and the Virological Effect of Delayed Treatment Switching to Second-Line Therapy in An Antiretroviral Roll-Out Programme in South AfricaAntiviral Therapy, 16
M. Török, J. Farrar (2011)
When to start antiretroviral therapy in HIV-associated tuberculosis.The New England journal of medicine, 365 16
S. Serrano-Villar, V. Estrada, D. Gómez-Garre, M. Ávila, M. Fuentes-Ferrer, C. Sánchez-Parra, T. Sainz, R. Patiño, A. Fernandez-cruz (2012)
Incipient Renal Impairment as a Predictor of Subclinical Atherosclerosis in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 59
A. Morris, Matthew Gingo, M. George, L. Lucht, C. Kessinger, Vikas Singh, M. Hillenbrand, M. Busch, D. McMahon, K. Norris, H. Champion, M. Gladwin, Yingze Zhang, C. Steele, F. Sciurba (2012)
Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy eraAIDS, 26
L. Skoura, S. Metallidis, A. Buckton, J. Mbisa, D. Pilalas, E. Papadimitriou, A. Papoutsi, A. Haidich, T. Chrysanthidis, O. Tsachouridou, Z. Antoniadou, P. Kollaras, P. Nikolaidis, N. Malisiovas (2011)
Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece.The Journal of antimicrobial chemotherapy, 66 12
Ursula Gompels, Natasha Larke, Marta Sanz-Ramos, Matthew Bates, Kunda Musonda, Daniela Manno, J. Siame, M. Monze, Suzanne Filteau (2012)
Human Cytomegalovirus Infant Infection Adversely Affects Growth and Development in Maternally HIV-Exposed and Unexposed Infants in ZambiaClinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 54
G. Vallecillo, P. Domingo, J. Mallolas, J. Blanch, E. Ferrer, M. Cervantes, E. Pedrol, H. Knobel, J. Llibre (2012)
Evaluation of the safety and effectiveness of nevirapine plus coformulated tenofovir/emtricitabine as first-line therapy in routine clinical practice.AIDS research and human retroviruses, 28 2
(2011)
A doseresponse relationship between exposure to a large-scale HIV preventive intervention and consistent condom use with different sexual partners of female sex workers in southern India - art
J. Llibre, J. Arribas, P. Domingo, J. Gatell, F. Lozano, J. Santos, A. Rivero, S. Moreno, B. Clotet (2011)
Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapyAIDS, 25
(2011)
Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort -art. no. e1001055
Christine Dao, P. Peters, J. Kiarie, I. Zulu, P. Muiruri, J. Ong'ech, W. Mutsotso, D. Potter, L. Njobvu, J. Stringer, C. Borkowf, O. Bolu, P. Weidle (2011)
Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women.AIDS research and human retroviruses, 27 11
H. Ajoge, M. Gordon, S. Ibrahim, O. Shittu, T. Ndung’u, S. Olonitola (2012)
Drug resistance pattern of HIV type 1 isolates sampled in 2007 from therapy-naive pregnant women in North-Central Nigeria.AIDS research and human retroviruses, 28 1
Jeffrey Eaton, Nuala McGrath, Marie-Louise Newell (2012)
Unpacking the recommended indicator for concurrent sexual partnershipsAIDS, 26
E. Ouattara, X. Anglaret, Angela Wong, J. Chu, H. Hsu, C. Danel, S. Eholie, R. Moh, D. Gabillard, R. Walensky, K. Freedberg (2012)
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing ageAIDS, 26
D. Costagliola, R. Lodwick, B. Ledergerber, C. Torti, A. Sighem, D. Podzamczer, A. Mocroft, M. Dorrucci, B. Masquelier, A. Luca, K. Jansen, S. Wit, N. Obel, G. Fätkenheuer, Giota Touoloumi, C. Mussini, A. Castagna, C. Stephan, Federico García, R. Zangerle, X. Duval, S. Pérez-Hoyos, L. Meyer, J. Ghosn, C. Fabre-Colin, J. Kjaer, G. Chêne, J. Grarup, A. Phillips (2012)
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study.The Lancet. Infectious diseases, 12 2
S. Thorat, Devidas Chaturbhuj, Nitin Hingankar, Velura Chandrasekhar, Rajasekhar Koppada, Sharda Datkar, P. Srikantiah, R. Garg, S. Kabra, P. Haldar, D. Reddy, D. Bachani, S. Tripathy, R. Paranjape (2011)
Surveillance of transmitted HIV type 1 drug resistance among HIV type 1-positive women attending an antenatal clinic in Kakinada, India.AIDS research and human retroviruses, 27 12
(2011)
Remarks on ’Creating an AIDS-Free Generation
E. Mills, N. Ford (2012)
Political lessons from the global HIV/AIDS response to inform a rapid noncommunicable disease response.AIDS, 26 9
A. Cavalcanti, A. Brito, D. Salustiano, Kledoaldo Lima, S. Silva, R. Diaz, H. Lacerda (2012)
Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco.Memorias do Instituto Oswaldo Cruz, 107 4
M. Lanzafame, E. Lattuada, G. Zoppini, Sandro Vento (2011)
Antiretroviral therapy-associated diseases are common in the long-term.AIDS research and human retroviruses, 27 9
J. Amo, S. Moreno, H. Bucher, H. Furrer, R. Logan, J. Sterne, S. Pérez-Hoyos, I. Jarrín, A. Phillips, S. Lodi, A. Sighem, Wolf Wolf, C. Sabin, L. Bansi, A. Justice, J. Goulet, J. Miro, E. Ferrer, L. Meyer, R. Seng, Giota Toulomi, P. Gargalianos, D. Costagliola, S. Abgrall, M. Hernán (2012)
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 9
Nicole Schmidt, José Roman-Pouriet, Aracelis Fernandez, C. Beck-Sague, José Leonardo-Guerrero, S. Nicholas (2012)
Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother‐to‐child transmission of HIV in the Dominican RepublicInternational Journal of Gynecology & Obstetrics, 116
Lorainne Car, M. van-Velthoven, S. Brusamento, Hoda Elmoniry, J. Car, A. Majeed, R. Atun (2011)
Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.The Cochrane database of systematic reviews, 6
Robert Smith, Dana Raugi, N. Kiviat, S. Hawes, J. Mullins, P. Sow, G. Gottlieb (2011)
Phenotypic susceptibility of HIV-2 to raltegravir: integrase mutations Q148R and N155H confer raltegravir resistanceAIDS, 25
M. Rabkin, M. Kruk, W. El-Sadr (2012)
HIV, aging and continuity care: strengthening health systems to support services for noncommunicable diseases in low-income countriesAIDS, 26
N. Jack, G. Ravasi, W. Schrooten, D. Sutherland, M. Ghidinelli, A. Riego (2012)
Implementing early-warning indicators of HIV drug resistance in the Caribbean.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
E. Hammond, E. McKinnon, P. Glendenning, R. Williams, S. Mallal, E. Phillips (2012)
Association between 25‐OH vitamin D and insulin is independent of lipoatrophy in HIVClinical Endocrinology, 76
P. Zeng, Jing-xing Wang, Yi Huang, Xiaoming Guo, Julin Li, Guoxin Wen, Tonghan Yang, Z. Yun, M. He, Yu Liu, Yuzhe Yuan, Jane Schulmann, S. Glynn, P. Ness, J. Jackson, H. Shan (2012)
The human immunodeficiency virus‐1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centersTransfusion, 52
P. Kiser, T. Johnson, Justin Clark (2012)
State of the art in intravaginal ring technology for topical prophylaxis of HIV infection.AIDS reviews, 14 1
P. Marquez, J. Farrington (2012)
No more disease silos for sub-Saharan AfricaBMJ : British Medical Journal, 345
N. Katende-Kyenda, M. Lubbe, J. Serfontein, I. Truter (2012)
Identification of potential drug–drug interactions between antiretroviral drugs from prescriptions in the private health-care sector in South AfricaInternational Journal of STD & AIDS, 23
S. Hernández, C. Morén, Marta López, O. Coll, F. Cardellach, E. Gratacós, Ò. Miró, G. Garrabou (2012)
Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newbornAIDS, 26
T. Boyles (2012)
Timing of antiretroviral therapy for HIV-1-associated tuberculosis.The New England journal of medicine, 366 5
K. Narayan, Mohammed Ali, C. Rio, J. Koplan, J. Curran (2011)
Global noncommunicable diseases--lessons from the HIV-AIDS experience.The New England journal of medicine, 365 10
A. Cozzi-Lepri, A. Cozzi-Lepri, R. Paredes, A. Phillips, B. Clotet, J. Kjaer, V. Wyl, G. Kronborg, A. Castagna, J. Bogner, Jens Lundgren (2011)
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI *HIV Medicine, 13
(2011)
Prospective study of the ARCHITECTHIV Ag/Ab Combo fourth generation assay to detect HIV infection in sexually transmitted infection
T. Do, T. Nguyen, M. Do, Kato Masaya, Thi Dang, Thuỳ Phạm, K. Yoshikawa, T. Cao, Thi Nguyen, D. Bui, V. Nguyen, Thanh Nguyen, M. Fujita (2012)
Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
R. Westergaard, G. Kirk, Douglas Richesson, N. Galai, S. Mehta (2011)
Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 53 7
J. Grierson, R. Koelmeyer, A. Smith, M. Pitts (2011)
Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV‐positive AustraliansHIV Medicine, 12
C. Dieffenbach (2012)
Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda.Current opinion in HIV and AIDS, 7 2
(2011)
Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future researchart
Olawale Ajose, S. Mookerjee, E. Mills, A. Boulle, N. Ford (2012)
Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysisAIDS, 26
J. Pérez-Molina, M. Díaz-Menéndez, M. Plana, J. Zamora, R. López-Vélez, S. Moreno (2012)
Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials.The Journal of antimicrobial chemotherapy, 67 2
R. Sherer (2011)
The future of HIV care in the USASexually Transmitted Infections, 88
E. Kalmar, S. Sanabani, A. Costa, Suzete Ferreira, C. Barreto, S. Chen, E. Sabino (2012)
Evaluation of HIV-1 resistance to antiretroviral drugs among 150 patients after six months of therapeutic interruptionInternational Journal of STD & AIDS, 23
(2011)
HIV treatment for prevention - art
C. Morrison, Stephanie Skoler-Karpoff, C. Kwok, Pai-Lien Chen, J. Wijgert, Marlena Gehret-Plagianos, S. Patel, K. Ahmed, G. Ramjee, B. Friedland, P. Lahteenmaki (2012)
Hormonal contraception and the risk of HIV acquisition among women in South AfricaAIDS, 26
Z. Yin, B. Rice, P. Waight, E. Miller, R. George, A. Brown, Ruth Smith, M. Slack, V. Delpech (2012)
Invasive pneumococcal disease among HIV-positive individuals, 2000–2009AIDS, 26
I. Peterson, O. Togun, Thushan Silva, F. Oko, S. Rowland-Jones, A. Jaye, K. Peterson (2011)
Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the GambiaAIDS, 25
M. Masiá, S. Padilla, Catalina Robledano, N. López, J. Ramos, F. Gutiérrez (2012)
Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir.AIDS research and human retroviruses, 28 3
C. Hurt, J. Eron, M. Cohen (2011)
Pre-exposure prophylaxis and antiretroviral resistance: HIV prevention at a cost?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 53 12
(2012)
How much can we gain from improved efficiency? An examination of performance of national HIV/AIDS programs and its determinants in low- and middle-income countries - art
Bin Zhao, Xiaoxu Han, Di Dai, Jing Liu, Haibo Ding, Junjie Xu, Zhenxing Chu, T. Bice, Yingying Diao, H. Shang (2011)
New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.AIDS research and human retroviruses, 27 10
A. Choko, N. Desmond, Emily Webb, Kondwani Chavula, Sue Napierala-Mavedzenge, C. Gaydos, S. Makombe, Treza Chunda, S. Squire, N. French, V. Mwapasa, Elizabeth Corbett (2011)
The Uptake and Accuracy of Oral Kits for HIV Self-Testing in High HIV Prevalence Setting: A Cross-Sectional Feasibility Study in Blantyre, MalawiPLoS Medicine, 8
Nitin Hingankar, S. Thorat, A. Deshpande, S. Rajasekaran, C. Chandrasekar, Suria Kumar, P. Srikantiah, Devidas Chaturbhuj, Sharda Datkar, P. Deshmukh, S. Kulkarni, S. Sane, D. Reddy, R. Garg, M. Jordan, M. Jordan, S. Kabra, S. Tripathy, R. Paranjape (2012)
Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
Esorom Daoni, Urarang Kitur, Apa Parunga, Fabian Ndenzako, A. Lloyd, Dongbao Yu (2012)
Experience in piloting HIV drug resistance early warning indicators to improve the antiretroviral program in Papua New Guinea.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
M. Magee, H. Blumberg, D. Broz, S. Furner, Luke Samson, Sarman Singh, R. Hershow (2012)
Prevalence of drug resistant tuberculosis among patients at high-risk for Hiv attending outpatient clinics in Delhi, India.The Southeast Asian journal of tropical medicine and public health, 43 2
William Westera, John Koethea, Bryan Shepherda, Samuel Stinnettea, Peter Rebeiroa, Aaron Kippa, Hwanhee Hongb, Hermann Bussmannb, Tendani Gaolathec, Catherine McGowana, Timothy Sterlinga, Richard Marlinkb (2011)
Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban settingAIDS, 25
Sarah Lorenzana, M. Hughes, B. Grinsztejn, A. Collier, P. Luz, K. Freedberg, R. Wood, J. Levison, P. Mugyenyi, R. Salata, C. Wallis, M. Weinstein, R. Schooley, R. Walensky (2012)
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trialAIDS, 26
D. Evans, M. Maskew, I. Sanne (2012)
Increased risk of mortality and loss to follow-up among HIV-positive patients with oropharyngeal candidiasis and malnutrition before antiretroviral therapy initiation: a retrospective analysis from a large urban cohort in Johannesburg, South Africa.Oral surgery, oral medicine, oral pathology and oral radiology, 113 3
M. Thigpen, P. Kebaabetswe, L. Paxton, Dawn Smith, C. Rose, Tebogo Segolodi, Faith Henderson, S. Pathak, F. Soud, K. Chillag, Rodreck Mutanhaurwa, Lovemore Chirwa, M. Kasonde, Daniel Abebe, Evans Buliva, R. Gvetadze, Sandra Johnson, T. Sukalac, Vasavi Thomas, C. Hart, Jeffrey Johnson, C. Malotte, C. Hendrix, J. Brooks (2012)
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.The New England journal of medicine, 367 5
S. Fourati, I. Malet, C. Guenzel, C. Soulié, Priscilla Maidou-Peindara, L. Morand‐Joubert, M. Wirden, S. Sayon, G. Peytavin, A. Simon, C. Katlama, S. Bénichou, V. Calvez, A. Marcelin (2012)
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations.Antiviral research, 93 1
Michael Rayment (2011)
Prevention of HIV-1 infection with early antiretroviral therapyJournal of Family Planning and Reproductive Health Care, 38
D. Gibb, H. Kizito, Elizabeth Russell, E. Chidziva, E. Zalwango, R. Nalumenya, M. Spyer, D. Tumukunde, K. Nathoo, P. Munderi, H. Kyomugisha, J. Hakim, H. Grosskurth, C. Gilks, A. Walker, P. Musoke (2012)
Pregnancy and Infant Outcomes among HIV-Infected Women Taking Long-Term ART with and without Tenofovir in the DART TrialPLoS Medicine, 9
S. Koenig, Luis Rodríguez, C. Bartholomew, Alison Edwards, Tracie Carmichael, G. Barrow, A. Cabié, R. Hunter, Giselle Vasquez-Mora, Avion Quava-Jones, N. Adomakoh, J. Figueroa, B. Liautaud, M. Torres, J. Pape (2012)
Long-Term Antiretroviral Treatment Outcomes in Seven Countries in the CaribbeanJAIDS Journal of Acquired Immune Deficiency Syndromes, 59
M. Mascolini, J. Mellors, D. Richman, C. Boucher, B. Larder (2011)
HIV and Hepatitis Virus Resistance to Antivirals: Review of Data from the Xix International HIV and Hepatitis Virus Drug Resistance Workshop and Curative StrategiesAntiviral Therapy, 16
J. Pavie, R. Porcher, C. Torti, J. Medrano, A. Castagna, N. Valin, S. Rusconi, A. Ammassari, J. Ghosn, C. Delaugerre, J. Molina (2011)
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy.The Journal of antimicrobial chemotherapy, 66 10
K. Alcântara, J. Lins, M. Albuquerque, Letícia Aires, L. Cardoso, A. Minuzzi, M. Stefani (2012)
HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 54 1
R. Dray-Spira, C. Legeai, Mariette Den, F. Boué, C. Lascoux-Combe, A. Simon, T. May, C. Goujard, L. Meyer (2012)
Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies useAIDS, 26
R. Barth, S. Aitken, H. Tempelman, S. Geelen, E. Bussel, A. Hoepelman, R. Schuurman, A. Wensing (2012)
Accumulation of Drug Resistance and Loss of Therapeutic Options Precede Commonly Used Criteria for Treatment Failure in HIV-1 Subtype-C-Infected PatientsAntiviral Therapy, 17
K. Grépin (2011)
Leveraging HIV Programs to Deliver an Integrated Package of Health Services: Some Words of CautionJAIDS Journal of Acquired Immune Deficiency Syndromes, 57
J. Klausner, Celicia Serenata, Heidi O'bra, C. Mattson, Jw Brown, M. Wilson, T. Mbengashe, Thurma Goldman (2011)
Scale-Up and Continuation of Antiretroviral Therapy in South African Treatment Programs, 2005–2009JAIDS Journal of Acquired Immune Deficiency Syndromes, 56
C. Torti, M. Prosperi, D. Motta, S. Digiambenedetto, F. Maggiolo, G. Paraninfo, D. Ripamonti, G. Cologni, M. Fabbiani, S. Caputo, L. Sighinolfi, N. Ladisa, I. El-Hamad, E. Quiros-Roldan, I. Frank (2012)
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 18 5
X. Anglaret, A. Minga, D. Gabillard, T. Ouassa, E. Messou, B. Morris, M. Traoré, A. Coulibaly, K. Freedberg, C. Lewden, H. Menan, Y. Abo, N. Dakoury-Dogbo, S. Touré, C. Seyler (2012)
AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 5
A. Durval, L. Zamidei, D. Bettocchi, M. Luzzio, G. Consales (2011)
Hyperlipidemic acute pancreatitis: a possible role of antiretroviral therapy with entecavir.Minerva anestesiologica, 77 10
L. Jones, Paula Akugizibwe, M. Clayton, J. Amon, M. Sabin, R. Bennett, C. Stegling, R. Baggaley, J. Kahn, C. Holmes, N. Garg, C. Obermeyer, C. Mack, Phoebe Williams, C. Smyth, M. Vitoria, S. Crowley, B. Williams, C. McClure, R. Granich, G. Hirnschall (2011)
Costing Human Rights and Community Support Interventions as a Part of Universal Access to HIV Treatment and Care in a Southern African SettingCurrent HIV Research, 9
N. Ford (2012)
Commentary: the past, present and future of affordable antiretroviral therapy in Africa.International journal of epidemiology, 41 2
D. Bennett, M. Jordan, S. Bertagnolio, Steven Hong, G. Ravasi, J. McMahon, A. Saadani, K. Kelley (2012)
HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
Erika Silva, F. Fonseca, C. França, P. Ferreira, M. Izar, R. Salomão, L. Camargo, S. Tenore, D. Lewi (2011)
Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapyAIDS, 25
J. Jensen, A. Alvaro-Meca, D. Micheloud, A. Díaz, S. Resino (2012)
Reduction in Mycobacterial Disease Among HIV-infected Children in the Highly Active Antiretroviral Therapy Era (1997–2008)The Pediatric Infectious Disease Journal, 31
M. Andreoni, C. Perno (2012)
Positioning of HIV-protease inhibitors in clinical practice.European review for medical and pharmacological sciences, 16 1
H. Bailey, C. Townsend, M. Cortina-Borja, C. Thorne (2011)
Insufficient Antiretroviral Therapy in Pregnancy: Missed Opportunities for Prevention of Mother-To-Child Transmission of HIV in EuropeAntiviral Therapy, 16
S. Kiwuwa-Muyingo, S. Kiwuwa-Muyingo, A. Walker, Hannu Oja, J. Levin, G. Miiro, E. Katabira, C. Kityo, J. Hakim, J. Todd (2012)
The impact of first year adherence to antiretroviral therapy on long‐term clinical and immunological outcomes in the DART trial in Uganda and ZimbabweTropical Medicine & International Health, 17
M. Thompson, J. Aberg, J. Hoy, A. Telenti, C. Benson, P. Cahn, J. Eron, H. Günthard, S. Hammer, P. Reiss, D. Richman, G. Rizzardini, David Thomas, D. Jacobsen, P. Volberding (2012)
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.JAMA, 308 4
D. Chege, C. Kovacs, C. Porte, M. Ostrowski, J. Raboud, Desheng Su, G. Kandel, J. Brunetta, Connie Kim, P. Sheth, R. Kaul, M. Loutfy (2012)
Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trialAIDS, 26
G. Hunt, Ashraf Coovadia, E. Abrams, G. Sherman, T. Meyers, L. Morris, L. Kuhn (2011)
HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapineAIDS, 25
D. Röshammar, U. Simonsson, H. Ekvall, L. Flamholc, V. Ormaasen, J. Vesterbacka, E. Wallmark, M. Ashton, M. Gisslén (2011)
Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patientsJournal of Pharmacokinetics and Pharmacodynamics, 38
(2000)
Prevention of mother-tochild transmission of human immunodeficiency virus among pregnant women using injecting drugs
K. Kelley, Emily Caudwell, S. Xueref, T. Ha, S. Bertagnolio (2012)
Are countries using global fund support to implement HIV drug resistance surveillance? A review of funded HIV grants.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4
M. Prosperi, N. Mackie, S. Giambenedetto, M. Zazzi, R. Camacho, I. Fanti, C. Torti, A. Sönnerborg, R. Kaiser, F. Codoñer, K. Laethem, L. Bansi, D. Vijver, A. Geretti, A. Luca (2011)
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study.The Journal of antimicrobial chemotherapy, 66 8
K. Torpey, Lona Mwenda, Catherine Thompson, Edgar Wamuwi, W. Damme
Open Access Case Study from Project Aid to Sustainable Hiv Services: a Case Study from Zambia
D. Tho, M. Török, N. Yen, N. Bang, N. Lan, Vo Kiet, Nguyen Chau, N. Dung, J. Day, J. Farrar, M. Wolbers, M. Caws (2012)
Influence of Antituberculosis Drug Resistance and Mycobacterium tuberculosis Lineage on Outcome in HIV-Associated Tuberculous MeningitisAntimicrobial Agents and Chemotherapy, 56
H. McIlleron, R. Rustomjee, Mahnaz Vahedi, T. Mthiyane, P. Denti, C. Connolly, W. Rida, A. Pym, Peter Smith, P. Onyebujoh (2012)
Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing GuidelinesAntimicrobial Agents and Chemotherapy, 56
Geoffrey Preidis, E. McCollum, C. Mwansambo, P. Kazembe, G. Schutze, M. Kline (2011)
Pneumonia and malnutrition are highly predictive of mortality among African children hospitalized with human immunodeficiency virus infection or exposure in the era of antiretroviral therapy.The Journal of pediatrics, 159 3
M. Cohen, K. Muessig, M. Smith, K. Powers, A. Kashuba (2012)
Antiviral agents and HIV prevention: controversies, conflicts, and consensus.AIDS, 26 13
C. Staehelin, O. Keiser, A. Calmy, R. Weber, L. Elzi, M. Cavassini, P. Schmid, E. Bernasconi, H. Furrer (2012)
Longer Term Clinical and Virological Outcome of Sub-Saharan African Participants on Antiretroviral Treatment in the Swiss HIV Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 59
Shirin Heidari, L. Mofenson, C. Hobbs, M. Cotton, R. Marlink, E. Katabira (2012)
Unresolved Antiretroviral Treatment Management Issues in HIV-Infected ChildrenJAIDS Journal of Acquired Immune Deficiency Syndromes, 59
S. Pakkala, Zhengjia Chen, D. Rimland, T. Owonikoko, C. Gunthel, Johann Brandes, N. Saba, D. Shin, W. Curran, F. Khuri, S. Ramalingam (2012)
Human immunodeficiency virus‐associated lung cancer in the era of highly active antiretroviral therapyCancer, 118
M. Abouyannis, J. Menten, A. Kiragga, L. Lynen, Gavin Robertson, B. Castelnuovo, Y. Manabe, S. Reynolds, L. Roberts (2011)
Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan AfricaAIDS, 25
M. Milloy, T. Kerr, J. Buxton, T. Rhodes, A. Krusi, S. Guillemi, R. Hogg, J. Montaner, E. Wood (2012)
Social and Environmental Predictors of Plasma HIV RNA Rebound Among Injection Drug Users Treated With Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 59
P. Kohler, M. Chung, C. McGrath, S. Benki-Nugent, J. Thiga, G. John-Stewart (2011)
Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in KenyaAIDS, 25
B. Schwartländer, J. Stover, T. Hallett, R. Atun, C. Ávila, E. Gouws, M. Bartoš, P. Ghys, M. Opuni, D. Barr, R. Alsallaq, L. Bollinger, Marcelo Freitas, G. Garnett, C. Holmes, K. Legins, Y. Pillay, A. Stanciole, C. McClure, G. Hirnschall, M. Laga, N. Padian (2011)
Towards an improved investment approach for an effective response to HIV/AIDSThe Lancet, 377
Hao Zhang, Fang Qin, Wei-de Ye, Zeng-Peng Li, Songyao Ma, Yanping Xia, Yi Jiang, Jiayi Zhu, Yixue Li, Jian Zhang, Haifeng Chen (2011)
Revealing the Drug‐Resistant Mechanism for Diarylpyrimidine Analogue Inhibitors of HIV‐1 Reverse TranscriptaseChemical Biology & Drug Design, 78
J. Baeten, D. Donnell, P. Ndase, N. Mugo, J. Campbell, Jonathan Wangisi, J. Tappero, E. Bukusi, C. Cohen, E. Katabira, A. Ronald, Elioda Tumwesigye, E. Were, K. Fife, J. Kiarie, C. Farquhar, G. John-Stewart, Aloysious Kakia, J. Odoyo, A. Mucunguzi, E. Nakku-Joloba, R. Twesigye, K. Ngure, Cosmas Apaka, H. Tamooh, Fridah Gabona, A. Mujugira, D. Panteleeff, Katherine Thomas, L. Kidoguchi, M. Krows, Jennifer Revall, Susan Morrison, Harald Haugen, Mira Emmanuel-ogier, Lisa Ondrejcek, R. Coombs, L. Frenkel, C. Hendrix, Namandjé Bumpus, D. Bangsberg, J. Haberer, W. Stevens, J. Lingappa, C. Celum (2012)
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.The New England journal of medicine, 367 5
Chongyi Wei, A. Herrick, H. Raymond, A. Anglemyer, A. Gerbase, S. Noar (2011)
Social marketing interventions to increase HIV/STI testing uptake among men who have sex with men and male-to-female transgender women.The Cochrane database of systematic reviews, 9
Z. Fox, A. Cozzi-Lepri, A. Monforte, A. Karlsson, A. Phillips, G. Kronborg, J. Kjaer, B. Clotet, J. Lundgren (2011)
Predictors of Having a Resistance Test following Confirmed Virological Failure of Combination Antiretroviral Therapy: Data from EurosidaAntiviral Therapy, 16
L. Gallego, P. Barreiro, J. López-Ibor (2012)
Psychopharmacological treatments in HIV patients under antiretroviral therapy.AIDS reviews, 14 2
(2012)
Emerging transmitted HIV drug resistance mutations among HIV infected patients prior to start of first-line ART in multiple sites across China
Vilija Joyce, P. Barnett, Adam Chow, A. Bayoumi, S. Griffin, Huiying Sun, M. Holodniy, Sheldon Brown, T. Kyriakides, D. Cameron, M. Youle, M. Sculpher, A. Anis, D. Owens (2012)
Effect of Treatment Interruption and Intensification of Antiretroviral Therapy on Health-Related Quality of Life in Patients with Advanced HIVMedical Decision Making, 32
P. Banandur, S. Rajaram, S. Mahagaonkar, J. Bradley, B. Ramesh, R. Washington, J. Blanchard, S. Moses, C. Lowndes, M. Alary (2011)
Heterogeneity of the HIV epidemic in the general population of Karnataka state, south IndiaBMC Public Health, 11
T. Taniguchi, Diana Nurutdinova, Jessica Grubb, Nur Önen, E. Shacham, Michael Donovan, E. Overton (2012)
Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapy.AIDS research and human retroviruses, 28 3
R. Beall, R. Kuhn (2012)
Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database AnalysisPLoS Medicine, 9
J. Senise, A. Castelo, Marisol Martínez (2011)
Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.AIDS reviews, 13 4
Jia Liu, Xiangmei Chen, Q. Xie, Weidong Zhang, Lai Wei, T. Shen, Qiang Xu, H. Zhuang, F. Gao, F. Lu (2011)
Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China.AIDS research and human retroviruses, 27 8
R. Hamers, C. Wallis, C. Kityo, M. Siwale, P. Ive, M. Botes, K. Mandaliya, M. Wellington, A. Osibogun, W. Stevens, M. Vugt (2013)
Drug-resistant HIV-1 in sub-Saharan Africa: clinical and public health studies
G. Cutsem, Saphonn, S. Saramony, Ung Vibol, Fujie Zhang, N. Han, S. Saghayam, N. Kurniati, D. Muktiarti, S. Fong, M. Thien, N. Yusoff, Lc Hai, K. Razali (2011)
A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern AfricaJournal of the International AIDS Society, 14
Nicolas Grundmann, P. Iliff, J. Stringer, C. Wilfert (2011)
Presumptive diagnosis of severe HIV infection to determine the need for antiretroviral therapy in children less than 18 months of age.Bulletin of the World Health Organization, 89 7
Pei‐Ying Wu, C. Hung, Wen‐Chun Liu, Chia-Yin Hsieh, Hsin-Yun Sun, Ching-Lan Lu, Hsiu Wu, K. Chien (2012)
Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors.The Journal of antimicrobial chemotherapy, 67 4
(2012)
Comparison of clinical outcomes between hiv-infected patients with and without hcv co-infection in a resourcelimited setting
(2012)
Three I’s for HIV/TB and early ART to prevent HIV and TB: policy review of HIV and TB guidelines for high HIV/TB-burden African countries: 19th International AIDS Conference Washington D.C
J. Robertson, J. Feinberg (2012)
Darunavir: a nonpeptidic protease inhibitor for antiretroviral-naive and treatment-experienced adults with HIV infectionExpert Opinion on Pharmacotherapy, 13
P. Labarga (2012)
New DHHS guidelines recommend antiretroviral therapy to all HIV-infected persons.AIDS reviews, 14 2
D. Lin, J. Seabrook, D. Matsui, S. King, M. Rieder, Y. Finkelstein (2011)
Palatability, adherence and prescribing patterns of antiretroviral drugs for children with human immunodeficiency virus infection in CanadaPharmacoepidemiology and Drug Safety, 20
A. Mosam, F. Shaik, T. Uldrick, T. Esterhuizen, G. Friedland, D. Scadden, J. Aboobaker, H. Coovadia (2012)
A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 60
Margaret Brewinski, Karen Megazzini, Laura Hance, M. Cruz, N. Pavía-Ruz, M. Negra, F. Ferreira, H. Marques, R. Hazra (2011)
Dyslipidemia in a cohort of HIV-infected Latin American children receiving highly active antiretroviral therapy.Journal of tropical pediatrics, 57 5
J. Kay, H. Wanzira, T. Sandison, A. Kakuru, Victor Bigira, M. Kamya, J. Homsy, J. Tappero, D. Havlir, G. Dorsey, T. Ruel (2012)
Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda.Journal of tropical pediatrics, 58 3
A. Audelin, J. Gerstoft, N. Obel, L. Mathiesen, A. Laursen, C. Pedersen, H. Nielsen, Janne Jensen, L. Nielsen, C. Nielsen, L. Jørgensen (2011)
Molecular phylogenetics of transmitted drug resistance in newly diagnosed HIV Type 1 individuals in Denmark: a nation-wide study.AIDS research and human retroviruses, 27 12
T. Meyers, M. Yotebieng, L. Kuhn, H. Moultrie (2011)
Antiretroviral Therapy Responses Among Children Attending a Large Public Clinic in Soweto, South AfricaThe Pediatric Infectious Disease Journal, 30
A. Imaz, J. Llibre, E. Ribera, B. Clotet, D. Podzamczer (2011)
The role of inactive nucleoside/nucleotide reverse transcriptase inhibitors in salvage therapy for drug-resistant HIV-1 infection in the era of new classes and new generation antiretrovirals.Journal of acquired immune deficiency syndromes, 58 2
R. Sachdev, Shubha Bansal, R. Sinha, N. Sharma, J. Titiyal (2011)
Bilateral Microbial Keratitis in Highly Active Antiretroviral Therapy-induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Case SeriesOcular Immunology and Inflammation, 19
A. Violari, J. Lindsey, M. Hughes, H. Mujuru, Linda Barlow-Mosha, P. Kamthunzi, B. Chi, M. Cotton, H. Moultrie, S. Khadse, W. Schimana, R. Bobat, L. Purdue, S. Eshleman, E. Abrams, Linda Millar, E. Petzold, L. Mofenson, P. Jean‐Philippe, P. Palumbo (2012)
Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.The New England journal of medicine, 366 25
Meyrelane Ramos, S. Ferreira, C. Silva-Boghossian, R. Souto, A. Colombo, C. Noce, L. Gonçalves (2012)
Necrotizing periodontal diseases in HIV-infected Brazilian patients: a clinical and microbiologic descriptive study.Quintessence international, 43 1
J. Kim, E. Kim, J. Choi, Oh-Kyung Kwon, G. Kim, Suna Choi, S. Kim (2011)
Genetic variation of the HIV-1 integrase region in newly diagnosed anti-retroviral drug-naïve patients with HIV/AIDS in Korea.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 17 8
Susan Schader, Maureen Oliveira, Ruxandra-Ilinca Ibanescu, D. Moisi, S. Colby-Germinario, M. Wainberg (2011)
In Vitro Resistance Profile of the Candidate HIV-1 Microbicide Drug DapivirineAntimicrobial Agents and Chemotherapy, 56
A. Brennan, L. Long, M. Maskew, I. Sanne, Imogen Jaffray, P. Macphail, M. Fox (2011)
Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatmentAIDS, 25
S. Coleman, Aaron Blashill, R. Gandhi, S. Safren, O. Freudenreich (2012)
Impact of integrated and measurement-based depression care: clinical experience in an HIV clinic.Psychosomatics, 53 1
Margaret Rhoads, J. Lanigan, Colette Smith, E. Lyall (2011)
Effect of Specific ART Drugs on Lipid Changes and the Need for Lipid Management in Children With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 57
E. Hester (2012)
HIV medications: an update and review of metabolic complications.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 27 1
R. Hershow (2012)
Commentary on Thorne et al. (2012): HIV prevention and treatment in female injection drug users--a work in progress.Addiction, 107 1
C. Achenbach, R. Harrington, S. Dhanireddy, H. Crane, C. Casper, M. Kitahata (2012)
Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 3
B. Taylor, G. Hunt, E. Abrams, Ashraf Coovadia, T. Meyers, G. Sherman, R. Strehlau, L. Morris, L. Kuhn (2011)
Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa.AIDS research and human retroviruses, 27 9
G. Siberry, D. Harris, R. Oliveira, M. Krauss, C. Hofer, A. Tiraboschi, H. Marques, R. Succi, T. Abreu, M. Negra, L. Mofenson, R. Hazra (2012)
Evaluation of Viral Load Thresholds for Predicting New World Health Organization Stage 3 and 4 Events in HIV-Infected Children Receiving Highly Active Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 60
T. Gengiah, C. Baxter, L. Mansoor, A. Kharsany, S. Karim (2012)
A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infectionExpert Opinion on Investigational Drugs, 21
M. Boger, A. Bian, A. Shintani, G. Milne, J. Morrow, Husamettin Erdem, Valerie Mitchell, D. Haas, T. Hulgan (2011)
Sex Differences in Urinary Biomarkers of Vascular and Endothelial Function in HIV-Infected Persons Receiving Antiretroviral TherapyAntiviral Therapy, 17
G. Armstrong, Chumben Humtsoe, M. Kermode (2011)
HIV risk behaviours among injecting drug users in Northeast India following scale-up of a targeted HIV prevention programmeBMC Public Health, 11
T. Bärnighausen, K. Chaiyachati, N. Chimbindi, Ashleigh Peoples, J. Haberer, M. Newell (2011)
Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies.The Lancet. Infectious diseases, 11 12
T. Horvath, H. Azman, G. Kennedy, G. Rutherford (2012)
Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection.The Cochrane database of systematic reviews, 3
Zachary Tyerman, D. Aboulafia (2012)
Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy.AIDS reviews, 14 1
J. Fernández-Montero, P. Barreiro, J. Romero, V. Soriano (2012)
Antiretroviral drugs for pre-exposure prophylaxis of HIV infection.AIDS reviews, 14 1
S. Krown, D. Roy, Jeannette Lee, B. Dezube, E. Reid, R. Venkataramanan, Kelong Han, E. Cesarman, D. Dittmer (2012)
Rapamycin With Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 59
M. Lemoine, L. Serfaty, J. Capeau (2012)
From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and managementCurrent Opinion in Infectious Diseases, 25
J. Atashili, A. Adimora, P. Ndumbe, G. Ikomey, A. Rinas, E. Myers, J. Eron, Jennifer Smith, W. Miller (2012)
High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?Cancer epidemiology, 36 3
R. Haubrich, S. Riddler, H. Ribaudo, G. Direnzo, K. Klingman, K. Garren, D. Butcher, J. Rooney, D. Havlir, J. Mellors (2011)
Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infectionAIDS, 25
J. Mauskopf, A. Brogan, S. Talbird, Silas Martin (2012)
Cost-effectiveness of combination therapy with etravirine in treatment-experienced adults with HIV-1 infectionAIDS, 26
S. Hsieh, S-Y Chang, C. Hung, W. Sheng, M.-Y. Chen, S. Chang (2011)
Emerging HIV-1 resistance to tipranavir and darunavir in patients with virological failure to first-generation protease inhibitors in TaiwanInternational Journal of STD & AIDS, 22
ofteN oVerlap (2012)
Chronic care of HIV and noncommunicable diseases How to leverage tHe HIv experIence
E. Ota, Windy Wariki, R. Mori, N. Hori, K. Shibuya (2011)
Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in high-income countries.The Cochrane database of systematic reviews, 12
A. Straten, L. Damme, J. Haberer, D. Bangsberg (2012)
Unraveling the divergent results of pre-exposure prophylaxis trials for HIV preventionAIDS, 26
A. Grossman, F. Messerli, E. Grossman (2015)
Drug induced hypertension--An unappreciated cause of secondary hypertension.European journal of pharmacology, 763 Pt A
P. Vitiello, D. Brudney, Malcolm MacCartney, Ana García, Colette Smith, N. Marshall, M. Johnson, A. Geretti (2012)
Responses to Switching to Maraviroc-Based Antiretroviral Therapy in Treated Patients with Suppressed Plasma HIV-1-RNA LoadIntervirology, 55
C. Königs, C. Feiterna-Sperling, S. Esposito, C. Viscoli, R. Rosso, T. Kakuda, R. Leemans, M. Peeters, Rebecca Mack, I. Peeters, R. Sinha, K. Boven, C. Giaquinto (2012)
Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescentsAIDS, 26
Bibliography URRENT PINION This bibliography is compiled by clinicians from the relevant journals Contents scanned by this publication. It is based on the literature regularly pulled into our database from OvidSP (articles are generally added to the 15 million on ART by 2015: a realistic target or just a database about two and a half months after publication). In addition, dream the bibliography contains every paper annotated by reviewers; these 75 Treatment 2.0: catalyzing the next phase of treatment, care and references were obtained from a variety of bibliographic databases support and published between the beginning of the review period and the time 75 Scaling up antiretroviral therapy in resource-limited settings: of going to press. The bibliography has been grouped into topics that adapting guidance to meet the challenges relate to the reviews in this issue. 76 Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa Papers considered by the reviewers to be of special interest 77 Transmitted HIV drug resistance in Asia && Papers considered by the reviewers to be of outstanding interest 77 Optimizing HIV treatment The number in square brackets following a selected paper, e.g. [7], 79 Fifteen million people on antiretroviral treatment
Current Opinion in HIV and Aids – Wolters Kluwer Health
Published: Jan 1, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.